Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 46
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

In vivo binding of PRDM9 reveals interactions with noncanonical genomic sites

  • Grey, Corinne
  • Clément, Julie A.J.
  • Buard, Jerome
  • Leblanc, Benjamin
  • Gut, Ivo Glynne
  • Gut, Marta
  • Duret, Laurent
  • de Massy, Bernard D.
In mouse and human meiosis, DNA double-strand breaks (DSBs) initiate homologous recombination and occur at specific sites called hotspots. The localization of these sites is determined by the sequence-specific DNA binding domain of the PRDM9 histone methyl transferase. Here, we performed an extensive analysis of PRDM9 binding in mouse spermatocytes. Unexpectedly, we identified a noncanonical recruitment of PRDM9 to sites that lack recombination activity and the PRDM9 binding consensus motif. These sites include gene promoters, where PRDM9 is recruited in a DSB-dependent manner. Another subset reveals DSB-independent interactions between PRDM9 and genomic sites, such as the binding sites for the insulator protein CTCF. We propose that these DSB-independent sites result from interactions between hotspot-bound PRDM9 and genomic sequences located on the chromosome axis., The work leading to the H3K4me3 results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 262055. This work was supported by the Agence Nationale de la Recherche (ANR-15-CE12-0010-01/DaSiRe). B.d.M. was funded by grants from the Centre National pour la Recherche Scientifique (CNRS) and the European Research Council Executive Agency under the European Community's Seventh Framework Programme (FP7/2007-2013 grant agreement no. [322788]).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing

  • Alioto, Tyler
  • Derdak, Sophia
  • Ribeca, Paolo
  • Castro Giner, Francesc
  • Beltran, Sergi
  • Raineri, Emanuele
  • Dabad, Marc
  • Heath, Simon
  • Gut, Marta
  • Gut, Ivo Glynne
Includes supplementary materials: online appendix; replication file, As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding of the variables affecting sequencing analysis output is required. Here using tumour-normal sample pairs from two different types of cancer, chronic lymphocytic leukaemia and medulloblastoma, we conduct a benchmarking exercise within the context of the International Cancer Genome Consortium. We compare sequencing methods, analysis pipelines and validation methods. We show that using PCR-free methods and increasing sequencing depth to ∼100 × shows benefits, as long as the tumour:control coverage ratio remains balanced. We observe widely varying mutation call rates and low concordance among analysis pipelines, reflecting the artefact-prone nature of the raw data and lack of standards for dealing with the artefacts. However, we show that, using the benchmark mutation set we have created, many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy., We thank the DKFZ Genomics and Proteomics Core Facility and the OICR Genome Technologies Platform for provision of sequencing services. Financial support was provided by the consortium projects READNA under grant agreement FP7 Health-F4-2008-201418, ESGI under grant agreement 262055, GEUVADIS under grant agreement 261123 of the European Commission Framework Programme 7, ICGC-CLL through the Spanish Ministry of Science and Innovation (MICINN), the Instituto de Salud Carlos III (ISCIII) and the Generalitat de Catalunya. Additional financial support was provided by the PedBrain Tumor Project contributing to the ICGC, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants #01KU1201A, MedSys #0315416C and NGFNplus #01GS0883), the BMBF-funded ICGC projects on early-onset prostate cancer and malignant lymphoma (#01KU1001A, #01KU1002B) and via the BMBF-funded de.NBI HD-HuB network (#031A537A, #031A537C); the Ontario Institute for Cancer Research to PCB and JDM through funding provided by the Government of Ontario, Ministry of Research and Innovation; Genome Canada; the Canada Foundation for Innovation and Prostate Cancer Canada with funding from the Movember Foundation (PCB). P.C.B. was also supported by a Terry Fox Research Institute New Investigator Award, a CIHR New Investigator Award and a Genome Canada Large-Scale Applied Project Contract. The Synergie Lyon Cancer platform has received support from the French National Institute of Cancer (INCa) and from the ABS4NGS ANR project (ANR-11-BINF-0001-06). The ICGC RIKEN study was supported partially by RIKEN President’s Fund 2011, and the supercomputing resource for the RIKEN study was provided by the Human Genome Center, University of Tokyo. M.D.E., L.B., A.G.L. and C.L.A. were supported by Cancer Research UK, the University of Cambridge and Hutchison-Whampoa Limited. S.D. is supported by the Torres Quevedo subprogramme (MICINN) under grant agreement PTQ-12-05391. E.H. is supported by the Research Council of Norway under grant agreements 221580 and 218241 and by the Norwegian Cancer Society under grant agreement 71220—PR-2006-0433. We specially thank Jennifer Jennings for administrating the activity of the ICGC Verification Working Group and Anna Borrell for administrative support.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia.

  • Costas, Javier
  • Carrera, Noa
  • Alonso, Pino
  • Gurriarán, X.
  • Segalàs, Cinto
  • Real, Eva
  • López-Solà, Clara
  • Mas, Sebastian
  • Gassó, Patricia
  • Domènech Salgado, Laura, 1989-
  • Morell, Marta
  • Quintela Garcia, Ines
  • Lázaro, Luisa
  • Menchón, José M.
  • Estivill, Xavier, 1955-
  • Carracedo, Ángel
Common single-nucleotide polymorphisms (SNPs) account for a large proportion of the heritability of obsessive-compulsive disorder (OCD). Co-ocurrence of OCD and schizophrenia is commoner than expected based on their respective prevalences, complicating the clinical management of patients. This study addresses two main objectives: to identify particular genes associated with OCD by SNP-based and gene-based tests; and to test the existence of a polygenic risk shared with schizophrenia. The primary analysis was an exon-focused genome-wide association study of 370 OCD cases and 443 controls from Spain. A polygenic risk model based on the Psychiatric Genetics Consortium schizophrenia data set (PGC-SCZ2) was tested in our OCD data. A polygenic risk model based on our OCD data was tested on previous data of schizophrenia from our group. The most significant association at the gene-based test was found at DNM3 (P=7.9 × 10(-5)), a gene involved in synaptic vesicle endocytosis. The polygenic risk model from PGC-SCZ2 data was strongly associated with disease status in our OCD sample, reaching its most significant value after removal of the major histocompatibility complex region (lowest P=2.3 × 10(-6), explaining 3.7% of the variance). The shared polygenic risk was confirmed in our schizophrenia data. In conclusion, DNM3 may be involved in risk to OCD. The shared polygenic risk between schizophrenia and OCD may be partially responsible for the frequent comorbidity of both disorders, explaining epidemiological data on cross-disorder risk. This common etiology may have clinical implications., The study was supported by Fundación María José Jove, Fondo Europeo de Desarrollo Regional (FEDER), Xunta de Galicia; and by grants from the Instituto de Salud Carlos III FIS PI13/01136 to AC, CP11/00163 to JC, PI13/00918 to JMM, PI14/00413 to PA; the Generalitat de Catalunya AGAUR 2014 SGR-1138; the Spanish MINIECO SAF2013-49108- R Plan Estatal; and the European Commission 7th Framework Program, Project N. 262055 (ESGI) to XE. LD is supported by a Severo Ochoa fellowship of the Spanish MINIECO.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Container-aided integrative QTL and RNA-seq analysis of Collaborative Cross mice supports distinct sex-oriented molecular modes of response in obesity

  • Binenbaum, Ilona
  • Atamni, Hanifa Abu-Toamih
  • Fotakis, Georgios
  • Kontogianni, Georgia
  • Koutsandreas, Theodoros
  • Pilalis, Eleftherios
  • Mott, Richard
  • Himmelbauer, Heinz
  • Iraqi, Fuad A.
  • Chatziioannou, Aristotelis A.
Background: The Collaborative Cross (CC) mouse population is a valuable resource to study the genetic basis of complex traits, such as obesity. Although the development of obesity is influenced by environmental factors, underlying genetic mechanisms play a crucial role in the response to these factors. The interplay between the genetic background and the gene expression pattern can provide further insight into this response, but we lack robust and easily reproducible workflows to integrate genomic and transcriptomic information in the CC mouse population. Results: We established an automated and reproducible integrative workflow to analyse complex traits in the CC mouse genetic reference panel at the genomic and transcriptomic levels. We implemented the analytical workflow to assess the underlying genetic mechanisms of host susceptibility to diet induced obesity and integrated these results with diet induced changes in the hepatic gene expression of susceptible and resistant mice. Hepatic gene expression differs significantly between obese and non-obese mice, with a significant sex effect, where male and female mice exhibit different responses and coping mechanisms. Conclusion: Integration of the data showed that different genes but similar pathways are involved in the genetic susceptibility and disturbed in diet induced obesity. Genetic mechanisms underlying susceptibility to high-fat diet induced obesity are different in female and male mice. The clear distinction we observed in the systemic response to the high-fat diet challenge and to obesity between male and female mice points to the need for further research into distinct sex-related mechanisms in metabolic disease., This work was funded by the Operational Program ”Competitiveness, Entrepreneurship and Innovation 2014–2020″ (co-funded by the European Regional Development Fund) and managed by the General Secretariat of Research and Technology, Ministry Of Education, Research & Religious Affairs, under the project” Innovative Nanopharmaceuticals: Targeting Breast CancerStem Cells by a Novel Combination of Epigenetic and Anticancer Drugs with Gene Therapy (INNOCENT)” (7th Joint Translational Call - 2016, European Innovative Research and Technological Development Projects In Nanomedicine) of the ERA-NET EuroNanoMed II and by “BioS: Digital Skills on Computational Biology”, ΕRASMUS+, EACEA/04/2017, “KA2: Cooperation for innovation and the exchange of good practices - Sector Skills Alliances” for the development of the bioinformatic analysis pipeline, Hendrech and Eiran Gotwert Fund for studying diabetes, Wellcome Trust grants 085906/Z/ 08/Z, 075491/Z/04 and 090532/Z/09/Z; for financially supporting the initiation, breeding, genotyping and maintaining the CC mouse colony at TAU, core funding by Tel-Aviv University (TAU) for supporting staff at Iraqi’s lab, Israeli Science foundation (ISF) grants 429/09 and 1085/18, Binational Science Foundation (BSF) grant number 2015077 and German Israeli Science Foundation (GIF) grant I-63-410.20-2017 for performing the mouse assessment for T2D and technical staff, and European Sequencing and Genotyping Infrastructure (ESGI) consortium grant for conducting the RNAseq analysis.Ilona Binenbaum’s PhD thesis was supported by a scholarship from the State Scholarship Foundation in Greece (IKY) (Operational Program “Human Resources Development - Education and Lifelong Learning” Partnership Agreement (PA) 2014–2020)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Biallelic loss-of-function LACC1/FAMIN mutations presenting as rheumatoid factor-negative polyarticular juvenile idiopathic arthritis

  • Rabionet Janssen, Raquel
  • Remesal, Agustín
  • Mensa Vilaró, Anna
  • Murías, Sara
  • Alcobendas, Rosa
  • González-Roca, Eva
  • Ruíz Ortiz, Estíbaliz
  • Antón, Jordi
  • Iglesias, Estibaliz
  • Modesto, Consuelo
  • Comas, David, 1969-
  • Puig, Anna
  • Drechsel, Oliver
  • Ossowski, Stephan
  • Yagüe, Jordi L.
  • Merino, Rosa
  • Estivill, Xavier, 1955-
  • Aróstegui Gorospe, Juan Ignacio
Juvenile idiopathic arthritis (JIA) is a complex rheumatic disease with both autoimmune and autoinflammatory components. Recently, familial cases of systemic-onset JIA have been attributed to mutations in LACC1/FAMIN. We describe three affected siblings from a Moroccan consanguineous family with an early-onset chronic, symmetric and erosive arthritis previously diagnosed as rheumatoid factor (RF)-negative polyarticular JIA. Autozygosity mapping identified four homozygous regions shared by all patients, located in chromosomes 3, 6 (n:2) and 13, containing over 330 genes. Subsequent whole exome sequencing identified two potential candidate variants within these regions (in FARS2 and LACC1/FAMIN). Genotyping of a cohort of healthy Moroccan individuals (n: 352) and bioinformatics analyses finally supported the frameshift c.128_129delGT mutation in the LACC1/FAMIN gene, leading to a truncated protein (p.Cys43Tyrfs*6), as the most probable causative gene defect. Additional targeted sequencing studies performed in patients with systemic-onset JIA (n:23) and RF-negative polyarticular JIA (n: 44) revealed no pathogenic LACC1/FAMIN mutations. Our findings support the homozygous genotype in the LACC1/FAMIN gene as the defect underlying the family here described with a recessively inherited severe inflammatory joint disease. Our evidences provide further support to the involvement of LACC1/FAMIN deficiency in different types of JIA in addition to the initially described systemic-onset JIA., This work has been partially funded by: CERCA Programme/Generalitat de Catalunya (JIA, XE, SO), the PERIS program of the Generalitat de Catalunya grant SLT002/16/00310 (RR), the Spanish Ministry of Economy and Competitiveness co-financed by European Regional Development Fund (ERDF) grant SAF2015-68472-C2-1-R (JIA), the Instituto de Salud Carlos III/Transnational Research Projects on Rare Diseases (JIA) grant AC15/00027, the Spanish Society of Pediatric Rheumatology (JIA), the Secretaria d’Universitats i Recerca del Departament d’Economia grant 2009-SGR-1502 (XE) and the European Union Seventh Framework Programme (FP7/2007-2013) grant agreement no. 262055 (XE).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Dissecting the effect of genetic variation on the hepatic expression of drug disposition genes across the collaborative cross mouse strains

  • Nachshon, Aharon
  • Abu-Toamih Atamni, Hanifa Jalal
  • Steuerman, Yael
  • Sheikh-Hamed, Roa'a
  • Dorman, Alexandra
  • Mott, Richard
  • Dohm, Juliana C.
  • Lehrach, Hans
  • Sultan, Marc
  • Shamir, Ron
  • Sauer, Sascha
  • Himmelbauer, Heinz
  • Iraqi, Fuad A.
  • Gat-Viks, Irit
A central challenge in pharmaceutical research is to investigate genetic variation in response to drugs. The Collaborative Cross (CC) mouse reference population is a promising model for pharmacogenomic studies because of its large amount of genetic variation, genetic reproducibility, and dense recombination sites. While the CC lines are phenotypically diverse, their genetic diversity in drug disposition processes, such as detoxification reactions, is still largely uncharacterized. Here we systematically measured RNA-sequencing expression profiles from livers of 29 CC lines under baseline conditions. We then leveraged a reference collection of metabolic biotransformation pathways to map potential relations between drugs and their underlying expression quantitative trait loci (eQTLs). By applying this approach on proximal eQTLs, including eQTLs acting on the overall expression of genes and on the expression of particular transcript isoforms, we were able to construct the organization of hepatic eQTL-drug connectivity across the CC population. The analysis revealed a substantial impact of genetic variation acting on drug biotransformation, allowed mapping of potential joint genetic effects in the context of individual drugs, and demonstrated crosstalk between drug metabolism and lipid metabolism. Our findings provide a resource for investigating drug disposition in the CC strains, and offer a new paradigm for integrating biotransformation reactions to corresponding variations in DNA sequences., This work was supported by the European Commission [FP7/2007-2013, under grant agreement no. 262055 (ESGI)], by the Israeli Centers of Research Excellence (I-CORE): Center No. 41/11, by the Broad-ISF grant 1168/14, and by the Wellcome Trust grants 090532/Z/09/Z, 085906/Z/08/Z, 083573/Z/07/Z, and 075491/Z/04. Research in the IG lab was supported by the European Research Council (637885), and by the Israeli Science Foundation (ISF) grant 1643/13. YS was partially supported by the Edmond J. Safra Center for Bioinformatics at Tel Aviv University IG is a Faculty Fellow of the Edmond J. Safra Center for Bioinformatics at Tel Aviv University and an Alon Fellow. RS was supported in part by the Raymond and Beverly Sackler Chair in Bioinformatics.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index

  • Hinney, Anke
  • Price Foundation Collaborative Group
  • Sunyer Deu, Jordi
  • Hebebrand, Johannes
The maintenance of normal body weight is disrupted in patients with anorexia nervosa (AN) for prolonged periods of time. Prior to the onset of AN, premorbid body mass index (BMI) spans the entire range from underweight to obese. After recovery, patients have reduced rates of overweight and obesity. As such, loci involved in body weight regulation may also be relevant for AN and vice versa. Our primary analysis comprised a cross-trait analysis of the 1000 single-nucleotide polymorphisms (SNPs) with the lowest P-values in a genome-wide association meta-analysis (GWAMA) of AN (GCAN) for evidence of association in the largest published GWAMA for BMI (GIANT). Subsequently we performed sex-stratified analyses for these 1000 SNPs. Functional ex vivo studies on four genes ensued. Lastly, a look-up of GWAMA-derived BMI-related loci was performed in the AN GWAMA. We detected significant associations (P-values <5 × 10-5, Bonferroni-corrected P<0.05) for nine SNP alleles at three independent loci. Interestingly, all AN susceptibility alleles were consistently associated with increased BMI. None of the genes (chr. 10: CTBP2, chr. 19: CCNE1, chr. 2: CARF and NBEAL1; the latter is a region with high linkage disequilibrium) nearest to these SNPs has previously been associated with AN or obesity. Sex-stratified analyses revealed that the strongest BMI signal originated predominantly from females (chr. 10 rs1561589; Poverall: 2.47 × 10-06/Pfemales: 3.45 × 10-07/Pmales: 0.043). Functional ex vivo studies in mice revealed reduced hypothalamic expression of Ctbp2 and Nbeal1 after fasting. Hypothalamic expression of Ctbp2 was increased in diet-induced obese (DIO) mice as compared with age-matched lean controls. We observed no evidence for associations for the look-up of BMI-related loci in the AN GWAMA. A cross-trait analysis of AN and BMI loci revealed variants at three chromosomal loci with potential joint impact. The chromosome 10 locus is particularly promising given that the association with obesity was primarily driven by females. In addition, the detected altered hypothalamic expression patterns of Ctbp2 and Nbeal1 as a result of fasting and DIO implicate these genes in weight regulation., The authors express their gratitude to all participants. We thank the following sources for funding or research: the German Ministry for Education and Research (National Genome Research Net-Plus 01GS0820 and 01KU0903; AS, MK and the CSCC were supported by 01EO1002, 01EO1502), the German Research Foundation (DFG; HI865/2-1, SFB940/1, SCHE1648/1-3, TS226/3-1), the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement n°245009 and n°262055, and the National Institutes of Health (NIH; R01DK075787), funding to MHT from the Alexander von Humboldt Foundation, the Helmholtz Alliance ICEMED – Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association, the Helmholtz cross-program topic “Metabolic Dysfunction”, the WTCCC3 WT088827/Z/09 entitled “A genome wide association study of anorexia nervosa”.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

PeSV-Fisher: identification of somatic and non-somatic structural variants using nextgeneration sequencing data

  • Escaramís, Geòrgia
  • Tornador Antolin, Cristian, 1979-
  • Bassaganyas Bars, Laia, 1985-
  • Rabionet Janssen, Raquel
  • Tubio, José M. C.
  • Martínez Fundichely, Alexander, 1978-
  • Cáceres Aguilar, Mario
  • Gut, Marta
  • Ossowski, Stephan
  • Estivill, Xavier, 1955-
Next-generation sequencing technologies expedited research to develop efficient computational tools for the identification of structural variants (SVs) and their use to study human diseases. As deeper data is obtained, the existence of higher complexity SVs in some genomes becomes more evident, but the detection and definition of most of these complex rearrangements is still in its infancy. The full characterization of SVs is a key aspect for discovering their biological implications. Here we present a pipeline (PeSV-Fisher) for the detection of deletions, gains, intra- and inter-chromosomal translocations, and inversions, at very reasonable computational costs. We further provide comprehensive information on co-localization of SVs in the genome, a crucial aspect for studying their biological consequences. The algorithm uses a combination of methods based on paired-reads and read-depth strategies. PeSV-Fisher has been designed with the aim to facilitate identification of somatic variation, and, as such, it is capable of analysing two or more samples simultaneously, producing a list of non-shared variants between samples. We tested PeSV-Fisher on available sequencing data, and compared its behaviour to that of frequently deployed tools (BreakDancer and VariationHunter). We have also tested this algorithm on our own sequencing data, obtained from a tumour and a normal blood sample of a patient with chronic lymphocytic leukaemia, on which we have also validated the results by targeted re-sequencing of different kinds of predictions. This allowed us to determine confidence parameters that influence the reliability of breakpoint predictions., This work was supported by AGAUR (Generalitat de Catalunya, 2009 SGR 1502) (X.E.); CIBERESP (Instituto de Salud Carlos III) (G.E.); ESGI (European Commission, 262055_ESGI) (R.R., X.E.), ENGAGE (European Commission, ENGAGE_201413), TECHGENE (European Commission, TECHGENE_223143), and GEUVADIS (European Commission, 261123_GEUVADIS) (X.E.); NOVADIS (Ministerio de Ciencia y Technologia, SAF2008-00357) (X.E.); Galicia Government Xunta de Galicia (Spain) through the project number 10PXIB918057 (J.M.C.T.); MAEC-AEC1 Predoctoral Fellowship (Ministerio de Asuntos Exteriores y Cooperación, Spain) (A.M.F.); and Ramón y Cajal position and grant BFU2007-60930 (Ministerio de Educación y Ciencia) (M.C.).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Evidence for the biogenesis of more than 1,000 novel human microRNAs

  • Friedländer, Marc R.
  • Lizano, Esther, 1974-
  • Houben, Anna J.
  • Bezdan, Daniela
  • Bañez Coronel, Mónica
  • Kudla, Grzegorz
  • Mateu Huertas, Elisabet, 1983-
  • Kagerbauer, Birgit
  • González Morilla, Justo
  • Chen, Kevin C
  • LeProust, Emily M
  • Martí Puig, Eulàlia
  • Estivill, Xavier, 1955-
Background: MicroRNAs (miRNAs) are established regulators of development, cell identity and disease. Although nearly two thousand human miRNA genes are known and new ones are continuously discovered, no attempt has been made to gauge the total miRNA content of the human genome. Results: Employing an innovative computational method on massively pooled small RNA sequencing data, we report 2,469 novel human miRNA candidates of which 1,098 are validated by in-house and published experiments. Almost 300 candidates are robustly expressed in a neuronal cell system and are regulated during differentiation or when biogenesis factors Dicer, Drosha, DGCR8 or Ago2 are silenced. To improve expression profiling, we devised a quantitative miRNA capture system. In a kidney cell system, 400 candidates interact with DGCR8 at transcript positions that suggest miRNA hairpin recognition, and 1,000 of the new miRNA candidates interact with Ago1 or Ago2, indicating that they are directly bound by miRNA effector proteins. From kidney cell CLASH experiments, in which miRNA-target pairs are ligated and sequenced, we observe hundreds of interactions between novel miRNAs and mRNA targets. The novel miRNA candidates are specifically but lowly expressed, raising the possibility that not all may be functional. Interestingly, the majority are evolutionarily young and overrepresented in the human brain. Conclusions: In summary, we present evidence that the complement of human miRNA genes is substantially larger than anticipated, and that more are likely to be discovered in the future as more tissues and experimental conditions are sequenced to greater depth., This project was funded by the Spanish Plan Nacional SAF2008-00357 (NOVADIS); the Generalitat de Catalunya AGAUR 2009 SGR-1502; the Instituto de Salud Carlos III (FIS/FEDER PI11/00733); National Institutes of Health (R00HG004515 to KCC) and the European Commission 7th Framework Program, Projects N. 03790 (SIROCCO), N. 282510 (BLUEPRINT), N. 261123 (GEUVADIS) and N. 262055 (ESGI). MRF is supported by EMBO Long-Term fellowship ALTF 225–2011; EL is supported by the ICGC CLL-Genome project funded by the Spanish Ministry of Economy and Competiveness through the Instituto de Salud Carlos III. AJSH is a Marie Curie postdoctoral fellow supported by the European Commission 7th Framework Program under grant agreement N. 330133. MB-C is a Sara Borrell postdoctoral fellow supported by the Spanish Ministry of Economy and Competiveness. GK was supported by the Wellcome Trust Grant 097383 and by the MRC. EM–H is a PhD student from LaCaixa
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A decade of structural variants: description, history and methods to detect structural variation

  • Escaramís, Geòrgia
  • Docampo, Elisa
  • Rabionet Janssen, Raquel
In the past decade, the view on genomic structural variation (SV) has been changed completely. SVs, previously considered rare events, are now recognized as the largest source of interindividual genetic variation affecting more bases than single nucleotide polymorphisms, variable number of tandem repeats and other small genetic variants. They have also been shown to play a role in phenotypic variation and in disease. In this review, the authors will provide an introduction to SV; a short historical perspective on the research of this source of genomic variation; a description of the types of structural variants, and on how they may have arisen; and an overview on methods of detecting structural variants, focusing on the analysis of high-throughput sequencing data., E.D. is supported by a Marie Curie Intraeuropean Fellowship (IEF), R.R. is supported through the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 262055. We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017’, SEV-2012-0208, the ‘Secretaria d'Universitats i Recerca del Departament d'Economia’ (2009 SGR 1502) and the ‘PN de I+D+I 2008-2011’ and ISCIII (SAF2008-00357). The research leading to these results reflects only the author s views and the funding agencies are not liable for any use that may be made of the information contained in this paper.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The European Genome-phenome Archive of human data consented for biomedical research

  • Lappalainen, Ilkka
  • Carreño Torres, Angel
  • Rambla de Argila, Jordi
  • Martinez Llobet, Oscar
  • Sitges Puy, Marc
  • Alberich, Mario
  • Torre, Sabela de la
  • Navarro i Cuartiellas, Arcadi, 1969-
  • Flicek, Paul
The European Genome-phenome Archive (EGA) is a permanent archive that promotes the distribution and sharing of genetic and phenotypic data consented for specific approved uses but not fully open, public distribution. The EGA follows strict protocols for information management, data storage, security and dissemination. Authorized access to the data is managed in partnership with the data-providing organizations. The EGA includes major reference data collections for human genetics research., The EGA has received support from the European Molecular Biology Laboratory, the European Union ELIXIR Technical Feasibility Study, the Wellcome Trust (grant WT 085475/C/08/Z), the UK Medical Research Council (grant G0800681), the Spanish Instituto de Salud Carlos III Instituto Nacional de Bioinformática (grant PT13/0001/0026), the Spanish Ministerio de Economía y Competitividad (MINECO) and Centro de Excelencia Severo Ochoa (grant SEV-2012-0208), the Fundació La Caixa and the Barcelona Supercomputing Centre. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013 under grant agreements 211601–ELIXIR, 200754–GEN2PHEN, 262055–ESGI, 242006–BASIS, 261376–IHMS and 305444–RD-CONNECT).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Identification of gene mutations and fusion genes in patients with Sézary syndrome.

  • Prasad, Aparna
  • Rabionet Janssen, Raquel
  • Espinet Solà, Blanca
  • Zapata Ortiz, Luis, 1985-
  • Puiggros Metje, Anna Maria
  • Melero Vilella, Maria Carme
  • Puig, Anna
  • Sarria-Trujillo, Yaris
  • Ossowski, Stephan
  • Garcia-Muret, Maria P.
  • Estrach, Teresa
  • Servitje, Octavio
  • Lopez-Lerma, Ingrid
  • Gallardo Hernández, Fernando
  • Pujol Vallverdú, Ramon Maria
  • Estivill, Xavier, 1955-
Sézary syndrome is a leukemic form of cutaneous T-cell lymphoma with an aggressive clinical course. The genetic etiology of the disease is poorly understood, with chromosomal abnormalities and mutations in some genes being involved in the disease. The goal of our study was to understand the genetic basis of the disease by looking for driver gene mutations and fusion genes in 15 erythrodermic patients with circulating Sézary cells, 14 of them fulfilling the diagnostic criteria of Sézary syndrome. We have discovered genes that could be involved in the pathogenesis of Sézary syndrome. Some of the genes that are affected by somatic point mutations include ITPR1, ITPR2, DSC1, RIPK2, IL6, and RAG2, with some of them mutated in more than one patient. We observed several somatic copy number variations shared between patients, including deletions and duplications of large segments of chromosome 17. Genes with potential function in the T-cell receptor signaling pathway and tumorigenesis were disrupted in Sézary syndrome patients, for example, CBLB, RASA2, BCL7C, RAMP3, TBRG4, and DAD1. Furthermore, we discovered several fusion events of interest involving RASA2, NFKB2, BCR, FASN, ZEB1, TYK2, and SGMS1. Our work has implications for the development of potential therapeutic approaches for this aggressive disease., This project was funded by “Retos de la Sociedad 2013: Europa Redes y Gestores” Programme from the Spanish Ministry of Economy and Competitiveness no. SAF2013-49108-R (to XE) and RD12/0036/0044 Red Temática de Investigación Cooperativa en Cancer, Fondo Europeo de Desarrollo Regional (to BE, FG, and RP), the Generalitat de Catalunya AGAUR 2014 SGR-1138 (to XE) and 2014 SGR-585 (to BE, A Puiggros, and FG), the European Commission 7th Framework Program (FP7/2007-2013) under grant agreement 282510 (A BLUEPRINT of haematopoietic Epigenomes to XE) and 262055 (European Sequencing and Genotyping Infrastructure to XE), Instituto de Salud Carlos III FEDER (PT13/0010/0005), and the “Xarxa de Bancs de tumors sponsored by Pla Director d’Oncologia de Catalunya.” We would also like to thank “Xarxa de Limfomes Cutanis de Catalunaya.” A Prasad is a Marie Curie Postdoctoral fellow supported by the European Commission 7th framework program (FP7/2007-2013) under grant agreement no. 625356. We acknowledge the support of the Spanish Ministry of Economy and Competitiveness, Centro de Excelencia Severo Ochoa 2013-2017, SEV-2012-0208.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing

  • Trujillano Lidón, Daniel, 1987-
  • Bullich, Gemma
  • Ossowski, Stephan
  • Ballarín, José
  • Torra, Roser
  • Estivill, Xavier, 1955-
  • Ars, Elisabet
Molecular diagnostics of autosomal dominant polycystic kidney disease (ADPKD) relies on mutation screening of PKD1 and PKD2, which is complicated by extensive allelic heterogeneity and the presence of six highly homologous sequences of PKD1. To date, specific sequencing of PKD1 requires laborious long-range amplifications. The high cost and long turnaround time of PKD1 and PKD2 mutation analysis using conventional techniques limits its widespread application in clinical settings. We performed targeted next-generation sequencing (NGS) of PKD1 and PKD2. Pooled barcoded DNA patient libraries were enriched by in-solution hybridization with PKD1 and PKD2 capture probes. Bioinformatics analysis was performed using an in-house developed pipeline. We validated the assay in a cohort of 36 patients with previously known PKD1 and PKD2 mutations and five control individuals. Then, we used the same assay and bioinformatics analysis in a discovery cohort of 12 uncharacterized patients. We detected 35 out of 36 known definitely, highly likely, and likely pathogenic mutations in the validation cohort, including two large deletions. In the discovery cohort, we detected 11 different pathogenic mutations in 10 out of 12 patients. This study demonstrates that laborious long-range PCRs of the repeated PKD1 region can be avoided by in-solution enrichment of PKD1 and PKD2 and NGS. This strategy significantly reduces the cost and time for simultaneous PKD1 and PKD2 sequence analysis, facilitating routine genetic diagnostics of ADPKD., This project was funded by the Spanish Plan Nacional SAF2008-00357 (NOVADIS); the Instituto de Salud Carlos III (FIS/FEDER PI11/00733; PI12/01523 and PI13/01731); the European Commission/n7th Framework Program, Project N. 261123 (GEUVADIS), and Project N. 262055 (ESGI); Spanish Renal Network for Research 16/06, RETICS, Instituto de Investigación Carlos III: REDinREN/RD06/0016 and RD012/0021 FEDER funds; the Catalan Government (AGAUR/n2009/SGR-1116); and the Fundación Renal Iñigo Álvarez de Toledo in Spain. D. T. is a PhD student supported by the Spanish Ministry of Economy and Competiveness. R. T. is supported by Intensification Programm of Research Activity ISCIII/Generalitat de Catalunya (programm I3SN). We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de/nExcelencia Severo Ochoa 2013-2017’, SEV-2012-0208.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

A genome-wide association study of anorexia nervosa

  • Fernández Aranda, Fernando
  • Jiménez-Murcia, Susana
  • Rabionet Janssen, Raquel
  • Genetic Consortium for Anorexia Nervosa
  • Wellcome Trust Case Control Consortium 3
Anorexia nervosa (AN) is a complex and heritable eating disorder characterized by dangerously low body weight. Neither candidate gene studies nor an initial genome-wide association study (GWAS) have yielded significant and replicated results. We performed a GWAS in 2907 cases with AN from 14 countries (15 sites) and 14 860 ancestrally matched controls as part of the Genetic Consortium for AN (GCAN) and the Wellcome Trust Case Control Consortium 3 (WTCCC3). Individual association analyses were conducted in each stratum and meta-analyzed across all 15 discovery data sets. Seventy-six (72 independent) single nucleotide polymorphisms were taken forward for in silico (two data sets) or de novo (13 data sets) replication genotyping in 2677 independent AN cases and 8629 European ancestry controls along with 458 AN cases and 421 controls from Japan. The final global meta-analysis across discovery and replication data sets comprised 5551 AN cases and 21 080 controls. AN subtype analyses (1606 AN restricting; 1445 AN binge-purge) were performed. No findings reached genome-wide significance. Two intronic variants were suggestively associated: rs9839776 (P = 3.01 x 10(-7)) in SOX2OT and rs17030795 (P = 5.84 x 10(-6)) in PPP3CA. Two additional signals were specific to Europeans: rs1523921 (P = 5.76 x 10(-6)) between CUL3 and FAM124B and rs1886797 (P = 8.05 x 10(-6)) near SPATA13. Comparing discovery with replication results, 76% of the effects were in the same direction, an observation highly unlikely to be due to chance (P= 4x10(-6)), strongly suggesting that true findings exist but our sample, the largest yet reported, was underpowered for their detection. The accrual of large genotyped AN case-control samples should be an immediate priority for the field.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Whole genome and exome sequencing of monozygotic twins discordant for Crohn's disease

  • Petersen, Britt-Sabina
  • Spehlmann, Martina E.
  • Raedler, Andreas
  • Stade, Björn
  • Thomsen, Ingo
  • Rabionet Janssen, Raquel
  • Rosenstiel, Philip
  • Schreiber, Stefan
  • Franke, Andre
Background Crohn's disease (CD) is an inflammatory bowel disease caused by genetic and environmental factors. More than 160 susceptibility loci have been identified for IBD, yet a large part of the genetic variance remains unexplained. Recent studies have demonstrated genetic differences between monozygotic twins, who were long thought to be genetically completely identical. Results We aimed to test if somatic mutations play a role in CD etiology by sequencing the genomes and exomes of directly affected tissue from the bowel and blood samples of one and the blood-derived exomes of two further monozygotic discordant twin pairs. Our goal was the identification of mutations present only in the affected twins, pointing to novel candidates for CD susceptibility loci. We present a thorough genetic characterization of the sequenced individuals but detected no consistent differences within the twin pairs. An estimate of the CD susceptibility based on known CD loci however hinted at a higher mutational load in all three twin pairs compared to 1,920 healthy individuals. Conclusion Somatic mosaicism does not seem to play a role in the discordance of monozygotic CD twins. Our study constitutes the first to perform whole genome sequencing for CD twins and therefore provides a valuable reference dataset for future studies. We present an example framework for mosaicism detection and point to the challenges in these types of analyses.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia

  • Costas, Javier
  • Carrera, Noa
  • Alonso, Pino
  • Gurriarán, X.
  • Segalàs Cosi, Cinto
  • Real, Eva
  • López Solà, Clara
  • Mas Herrero, Sergi
  • Gassó Astorga, Patricia
  • Domènech, Lluis
  • Morell, Marta
  • Quintela, Inés
  • Lázaro García, Luisa
  • Menchón Magriñá, José Manuel
  • Estivill, Xavier, 1955-
  • Carracedo, Arkaitz
Common single-nucleotide polymorphisms (SNPs) account for a large proportion of the heritability of obsessive-compulsive disorder (OCD). Co-ocurrence of OCD and schizophrenia is commoner than expected based on their respective prevalences, complicating the clinical management of patients. This study addresses two main objectives: to identify particular genes associated with OCD by SNP-based and gene-based tests; and to test the existence of a polygenic risk shared with schizophrenia. The primary analysis was an exon-focused genome-wide association study of 370 OCD cases and 443 controls from Spain. A polygenic risk model based on the Psychiatric Genetics Consortium schizophrenia data set (PGC-SCZ2) was tested in our OCD data. A polygenic risk model based on our OCD data was tested on previous data of schizophrenia from our group. The most significant association at the gene-based test was found at DNM3 (P=7.9 × 10(-5)), a gene involved in synaptic vesicle endocytosis. The polygenic risk model from PGC-SCZ2 data was strongly associated with disease status in our OCD sample, reaching its most significant value after removal of the major histocompatibility complex region (lowest P=2.3 × 10(-6), explaining 3.7% of the variance). The shared polygenic risk was confirmed in our schizophrenia data. In conclusion, DNM3 may be involved in risk to OCD. The shared polygenic risk between schizophrenia and OCD may be partially responsible for the frequent comorbidity of both disorders, explaining epidemiological data on cross-disorder risk. This common etiology may have clinical implications.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.

  • Alioto, Tyler S.
  • Buchhalter, Ivo
  • Derdak, Sophia
  • Hutter, Barbara
  • Eldridge, Matthew D.
  • Hovig, Eivind
  • Heisler, Lawrence E.
  • Beck, Timothy A.
  • Simpson, Jared T.
  • Tonon, Laurie
  • Sertier, Anne-Sophie
  • Patch, Ann-Marie
  • Jäger, Natalie
  • Ginsbach, Philip
  • Drews, Ruben
  • Paramasivam, Nagarajan
  • Kabbe, Rolf
  • Chotewutmontri, Sasithorn
  • Diessl, Nicolle
  • Previti, Christopher
  • Schmidt, Sabine
  • Brors, Benedikt
  • Feuerbach, Lars
  • Heinold, Michael
  • Gröbner, Susanne
  • Korshunov, Andrey
  • Tarpey, Patrick
  • Butler, Adam P.
  • Hinton, Jonathan
  • Jones, David T.W.
  • Menzies, Andrew
  • Raine, Keiran
  • Shepherd, Rebecca
  • Stebbings, Lucy
  • Teague, John W.
  • Ribeca, Paolo
  • Castro Giner, Francesc
  • Beltran i Agulló, Sergi
  • Raineri, Emanuele
  • Dabad, Marc
  • Heath, Simon C.
  • Gut, Marta
  • Denroche, Robert E.
  • Harding, Nicholas J.
  • Yamaguchi, Takafumi N.
  • Nakagawa, Hidewaki
  • Quesada, Victor
  • Valdés Mas, Rafael
  • Nakken, Sigve
  • Vodák, Daniel
  • Bower, Lawrence
  • Lynch, Andrew G.
  • Anderson, Charlotte L.
  • Waddell, Nicola
  • Pearson, John V.
  • Grimmond, Sean M.
  • Peto, Myron
  • Spellman, Paul
  • He, Minghui
  • Kandoth, Cyriac
  • Lee, Semin
  • Zhang, John
  • Létourneau, Louis
  • Ma, Singer
  • Seth, Sahil
  • Torrents Arenales, David
  • Xi, Liu
  • Wheeler, David A.
  • López-Otin, Carlos
  • Campo Güerri, Elias
  • Campbell, Peter J.
  • Boutros, Paul C.
  • Puente, Xose S.
  • Gerhard, Daniela S.
  • Pfister, Stefan M.
  • McPherson, John D.
  • Hudson, Thomas J.
  • Schlesner, Matthias
  • Lichter, Peter
  • Eils, Roland
  • Jones, David T.W.
  • Gut, Ivo G.
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding of the variables affecting sequencing analysis output is required. Here using tumour-normal sample pairs from two different types of cancer, chronic lymphocytic leukaemia and medulloblastoma, we conduct a benchmarking exercise within the context of the International Cancer Genome Consortium. We compare sequencing methods, analysis pipelines and validation methods. We show that using PCR-free methods and increasing sequencing depth to ∼ 100 × shows benefits, as long as the tumour:control coverage ratio remains balanced. We observe widely varying mutation call rates and low concordance among analysis pipelines, reflecting the artefact-prone nature of the raw data and lack of standards for dealing with the artefacts. However, we show that, using the benchmark mutation set we have created, many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Identification of gene mutations and fusion genes in patients with Sézary Syndrome

  • Prasad, Aparna
  • Rabionet Janssen, Raquel
  • Espinet Solà, Blanca
  • Zapata, Luis
  • Puiggròs Metje, Anna Maria
  • Melero, Carme
  • Puig, Anna
  • Sarria Trujillo, Yaris
  • Ossowski, Stephan
  • Garcia-Muret, Maria P.
  • Estrach Panella, Ma. Teresa (María Teresa)
  • Servitje Bedate, Octavio
  • Lopez Lerma, Ingrid
  • Gallardo, F. (Fernando)
  • Pujol, Ramon M.
  • Estivill, Xavier, 1955-
Sézary syndrome is a leukemic form of cutaneous T-cell lymphoma with an aggressive clinical course. The genetic etiology of the disease is poorly understood, with chromosomal abnormalities and mutations in some genes being involved in the disease. The goal of our study was to understand the genetic basis of the disease by looking for driver gene mutations and fusion genes in 15 erythrodermic patients with circulating Sézary cells, 14 of them fulfilling the diagnostic criteria of Sézary syndrome. We have discovered genes that could be involved in the pathogenesis of Sézary syndrome. Some of the genes that are affected by somatic point mutations include ITPR1, ITPR2, DSC1, RIPK2, IL6, and RAG2, with some of them mutated in more than one patient. We observed several somatic copy number variations shared between patients, including deletions and duplications of large segments of chromosome 17. Genes with potential function in the T-cell receptor signaling pathway and tumorigenesis were disrupted in Sézary syndrome patients, for example, CBLB, RASA2, BCL7C, RAMP3, TBRG4, and DAD1. Furthermore, we discovered several fusion events of interest involving RASA2, NFKB2, BCR, FASN, ZEB1, TYK2, and SGMS1. Our work has implications for the development of potential therapeutic approaches for this aggressive disease.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index

  • Hinney, Anke
  • Kesselmeier, Miriam
  • Jall, Sigrid
  • Volckmar, Anna-Lena
  • Föcker, Manuel
  • Antel, Jochen
  • GCAN
  • WTCCC3
  • Heid, Iris M.
  • Winkler, Thomas W.
  • GIANT
  • Grant, Struan F.
  • EGG
  • Guo, Yiran
  • Bergen, Andrew W.
  • Kaye, Walter H.
  • Berrettini, Wade
  • Hakonarson, Hakon
  • Price Foundation Collaborative Group
  • Children&apos;s Hospital of Philadelphia/Price Foundation
  • Herpertz-Dahlmann, B.
  • de Zwaan, Martina
  • Herzog, Wolfgang
  • Ehrlich, Stefan
  • Zipfel, Stephan
  • Egberts, Karin Maria
  • Adan, Roger A. H.
  • Brandys, Marek
  • van Elburg, Annemarie
  • Boraska Perica, Vesna
  • Franklin, Christopher S.
  • Tschöp, Matthias H.
  • Zeggini, Eleftheria
  • Bulik, Cynthia M.
  • Collier, David
  • Scherag, André
  • Müller, Timo D.
  • Hebebrand, Johannes
The maintenance of normal body weight is disrupted in patients with anorexia nervosa (AN) for prolonged periods of time. Prior to the onset of AN, premorbid body mass index (BMI) spans the entire range from underweight to obese. After recovery, patients have reduced rates of overweight and obesity. As such, loci involved in body weight regulation may also be relevant for AN and vice versa. Our primary analysis comprised a cross-trait analysis of the 1000 single nucleotide polymorphisms (SNPs) with the lowest p-values in a genome-wide association meta-analysis (GWAMA) of AN (GCAN) for evidence of association in the largest published GWAMA for BMI (GIANT). Subsequently we performed sex-stratified analyses for these 1000 SNPs. Functional ex vivo studies on four genes ensued. Lastly, a look-up of GWAMA-derived BMI related loci was performed in the AN GWAMA. We detected significant associations (p-values < 5×10−5, Bonferroni corrected p < 0.05) for 9 SNP alleles at 3 independent loci. Interestingly, all AN susceptibility alleles were consistently associated with increased BMI. None of the genes (chr. 10: CTBP2, chr. 19: CCNE1, chr. 2: CARF and NBEAL1; the latter is a region with high linkage disequilibrium) nearest to these SNPs has previously been associated with AN or obesity. Sex-stratified analyses revealed that the strongest BMI signal originated predominantly from females (chr. 10 rs1561589; poverall: 2.47 × 10−06/pfemales: 3.45 × 10−07/pmales: 0.043). Functional ex vivo studies in mice revealed reduced hypothalamic expression of Ctbp2 and Nbeal1 after fasting. Hypothalamic expression of Ctbp2 was increased in diet induced obese (DIO) mice as compared to age-matched lean controls. We observed no evidence for associations for the look-up of BMI related loci in the AN GWAMA. A cross-trait analysis of AN and BMI loci revealed variants at three chromosomal loci with potential joint impact. The chromosome 10 locus is particularly promising given that the association with obesity was primarily driven by females. In addition, the detected altered hypothalamic expression patterns of Ctbp2 and Nbeal1 as a result of fasting and DIO implicate these genes in weight regulation.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Biallelic loss-of-function LACC1/FAMIN mutations presenting as rheumatoid factor-negative polyarticular juvenile idiopathic arthritis

  • Rabionet Janssen, Raquel
  • Remesal, Agustín
  • Mensa Vilaró, Anna
  • Murías, Sara
  • Alcobendas, Rosa
  • González-Roca, Eva
  • Ruiz Ortiz, Estíbaliz
  • Antón López, Jordi
  • Iglesias Jiménez, Estíbaliz
  • Modesto, Consuelo
  • Comas, David
  • Puig, Anna
  • Drechsel, Oliver
  • Ossowski, Stephan
  • Yagüe, Jordi
  • Merino, Rosa
  • Estivill, Xavier, 1955-
  • Aróstegui Gorospe, Juan Ignacio
Juvenile idiopathic arthritis (JIA) is a complex rheumatic disease with both autoimmune and autoinflammatory components. Recently, familial cases of systemic-onset JIA have been attributed to mutations in LACC1/FAMIN. We describe three affected siblings from a Moroccan consanguineous family with an early-onset chronic, symmetric and erosive arthritis previously diagnosed as rheumatoid factor (RF)-negative polyarticular JIA. Autozygosity mapping identified four homozygous regions shared by all patients, located in chromosomes 3, 6 (n:2) and 13, containing over 330 genes. Subsequent whole exome sequencing identified two potential candidate variants within these regions (in FARS2 and LACC1/FAMIN). Genotyping of a cohort of healthy Moroccan individuals (n: 352) and bioinformatics analyses finally supported the frameshift c.128_129delGT mutation in the LACC1/FAMIN gene, leading to a truncated protein (p.Cys43Tyrfs*6), as the most probable causative gene defect. Additional targeted sequencing studies performed in patients with systemic-onset JIA (n:23) and RF-negative polyarticular JIA (n: 44) revealed no pathogenic LACC1/FAMIN mutations. Our findings support the homozygous genotype in the LACC1/FAMIN gene as the defect underlying the family here described with a recessively inherited severe inflammatory joint disease. Our evidences provide further support to the involvement of LACC1/FAMIN deficiency in different types of JIA in addition to the initially described systemic-onset JIA.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The European Genome-phenome Archive of human data consented for biomedical research

  • Lappalainen, Ilkka
  • Navarro, Arcadi
  • Flicek, Paul
Lappalainen, Ilkka et al., The European Genome-phenome Archive (EGA) is a permanent archive that promotes the distribution and sharing of genetic and phenotypic data consented for specific approved uses but not fully open, public distribution. The EGA follows strict protocols for information management, data storage, security and dissemination. Authorized access to the data is managed in partnership with the data-providing organizations. The EGA includes major reference data collections for human genetics research., The EGA has received support from the European Molecular Biology Laboratory, the European Union ELIXIR Technical Feasibility Study, the Wellcome Trust (grant WT 085475/C/08/Z), the UK Medical Research Council (grant G0800681), the Spanish Instituto de Salud Carlos III Instituto Nacional de Bioinformática (grant PT13/0001/0026), the Spanish Ministerio de Economía y Competitividad (MINECO) and Centro de Excelencia Severo Ochoa (grant SEV-2012-0208), the Fundació La Caixa and the Barcelona Supercomputing Centre. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013 under grant agreements 211601–ELIXIR, 200754–GEN2PHEN, 262055–ESGI, 242006–BASIS, 261376–IHMS and 305444–RD-CONNECT)., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing

  • Alioto, Tyler S.
  • Buchhalter, Ivo
  • Derdak, Sophie
  • Torrents Rodas, David
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding of the variables affecting sequencing analysis output is required. Here using tumour-normal sample pairs from two different types of cancer, chronic lymphocytic leukaemia and medulloblastoma, we conduct a benchmarking exercise within the context of the International Cancer Genome Consortium. We compare sequencing methods, analysis pipelines and validation methods. We show that using PCR-free methods and increasing sequencing depth to ~100 × shows benefits, as long as the tumour:control coverage ratio remains balanced. We observe widely varying mutation call rates and low concordance among analysis pipelines, reflecting the artefact-prone nature of the raw data and lack of standards for dealing with the artefacts. However, we show that, using the benchmark mutation set we have created, many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index

  • Hinney, Anke
  • Kesselmeier, Miriam
  • Jall, Sigrid
  • Volckmar, Anna-Lena
  • Föcker, Manuel
  • Antel, Jochen
  • GCAN
  • WTCCC3
  • Heid, Iris M.
  • Winkler, Thomas W.
  • GIANT
  • Grant, Struan F.
  • EGG
  • Guo, Yiran
  • Bergen, Andrew W.
  • Kaye, Walter H.
  • Berrettini, Wade
  • Hakonarson, Hakon
  • Price Foundation Collaborative Group
  • Children's Hospital of Philadelphia/Price Foundation
  • Herpertz-Dahlmann, B.
  • de Zwaan, Martina
  • Herzog, Wolfgang
  • Ehrlich, Stefan
  • Zipfel, Stephan
  • Egberts, Karin Maria
  • Adan, Roger A. H.
  • Brandys, Marek
  • van Elburg, Annemarie
  • Boraska Perica, Vesna
  • Franklin, Christopher S.
  • Tschöp, Matthias H.
  • Zeggini, Eleftheria
  • Bulik, Cynthia M.
  • Collier, David
  • Scherag, André
  • Müller, Timo D.
  • Hebebrand, Johannes
The maintenance of normal body weight is disrupted in patients with anorexia nervosa (AN) for prolonged periods of time. Prior to the onset of AN, premorbid body mass index (BMI) spans the entire range from underweight to obese. After recovery, patients have reduced rates of overweight and obesity. As such, loci involved in body weight regulation may also be relevant for AN and vice versa. Our primary analysis comprised a cross-trait analysis of the 1000 single nucleotide polymorphisms (SNPs) with the lowest p-values in a genome-wide association meta-analysis (GWAMA) of AN (GCAN) for evidence of association in the largest published GWAMA for BMI (GIANT). Subsequently we performed sex-stratified analyses for these 1000 SNPs. Functional ex vivo studies on four genes ensued. Lastly, a look-up of GWAMA-derived BMI related loci was performed in the AN GWAMA. We detected significant associations (p-values < 5×10−5, Bonferroni corrected p < 0.05) for 9 SNP alleles at 3 independent loci. Interestingly, all AN susceptibility alleles were consistently associated with increased BMI. None of the genes (chr. 10: CTBP2, chr. 19: CCNE1, chr. 2: CARF and NBEAL1; the latter is a region with high linkage disequilibrium) nearest to these SNPs has previously been associated with AN or obesity. Sex-stratified analyses revealed that the strongest BMI signal originated predominantly from females (chr. 10 rs1561589; poverall: 2.47 × 10−06/pfemales: 3.45 × 10−07/pmales: 0.043). Functional ex vivo studies in mice revealed reduced hypothalamic expression of Ctbp2 and Nbeal1 after fasting. Hypothalamic expression of Ctbp2 was increased in diet induced obese (DIO) mice as compared to age-matched lean controls. We observed no evidence for associations for the look-up of BMI related loci in the AN GWAMA. A cross-trait analysis of AN and BMI loci revealed variants at three chromosomal loci with potential joint impact. The chromosome 10 locus is particularly promising given that the association with obesity was primarily driven by females. In addition, the detected altered hypothalamic expression patterns of Ctbp2 and Nbeal1 as a result of fasting and DIO implicate these genes in weight regulation.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Evidence for the biogenesis of more than 1,000 novel human microRNAs

  • Friedländer, Marc R.
  • Lizano, Esther, 1974-
  • Houben, Anna J.
  • Bezdan, Daniela
  • Bañez Coronel, Mónica
  • Kudla, Grzegorz
  • Mateu Huertas, Elisabet, 1983-
  • Kagerbauer, Birgit
  • González Morilla, Justo
  • Chen, Kevin C
  • LeProust, Emily M
  • Martí Puig, Eulàlia
  • Estivill, Xavier, 1955-
Background: MicroRNAs (miRNAs) are established regulators of development, cell identity and disease. Although nearly two thousand human miRNA genes are known and new ones are continuously discovered, no attempt has been made to gauge the total miRNA content of the human genome. Results: Employing an innovative computational method on massively pooled small RNA sequencing data, we report 2,469 novel human miRNA candidates of which 1,098 are validated by in-house and published experiments. Almost 300 candidates are robustly expressed in a neuronal cell system and are regulated during differentiation or when biogenesis factors Dicer, Drosha, DGCR8 or Ago2 are silenced. To improve expression profiling, we devised a quantitative miRNA capture system. In a kidney cell system, 400 candidates interact with DGCR8 at transcript positions that suggest miRNA hairpin recognition, and 1,000 of the new miRNA candidates interact with Ago1 or Ago2, indicating that they are directly bound by miRNA effector proteins. From kidney cell CLASH experiments, in which miRNA-target pairs are ligated and sequenced, we observe hundreds of interactions between novel miRNAs and mRNA targets. The novel miRNA candidates are specifically but lowly expressed, raising the possibility that not all may be functional. Interestingly, the majority are evolutionarily young and overrepresented in the human brain. Conclusions: In summary, we present evidence that the complement of human miRNA genes is substantially larger than anticipated, and that more are likely to be discovered in the future as more tissues and experimental conditions are sequenced to greater depth., This project was funded by the Spanish Plan Nacional SAF2008-00357 (NOVADIS); the Generalitat de Catalunya AGAUR 2009 SGR-1502; the Instituto de Salud Carlos III (FIS/FEDER PI11/00733); National Institutes of Health (R00HG004515 to KCC) and the European Commission 7th Framework Program, Projects N. 03790 (SIROCCO), N. 282510 (BLUEPRINT), N. 261123 (GEUVADIS) and N. 262055 (ESGI). MRF is supported by EMBO Long-Term fellowship ALTF 225–2011; EL is supported by the ICGC CLL-Genome project funded by the Spanish Ministry of Economy and Competiveness through the Instituto de Salud Carlos III. AJSH is a Marie Curie postdoctoral fellow supported by the European Commission 7th Framework Program under grant agreement N. 330133. MB-C is a Sara Borrell postdoctoral fellow supported by the Spanish Ministry of Economy and Competiveness. GK was supported by the Wellcome Trust Grant 097383 and by the MRC. EM–H is a PhD student from LaCaixa
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.

  • Alioto, Tyler S.
  • Buchhalter, Ivo
  • Derdak, Sophia
  • Hutter, Barbara
  • Eldridge, Matthew D.
  • Hovig, Eivind
  • Heisler, Lawrence E.
  • Beck, Timothy A.
  • Simpson, Jared T.
  • Tonon, Laurie
  • Sertier, Anne-Sophie
  • Patch, Ann-Marie
  • Jäger, Natalie
  • Ginsbach, Philip
  • Drews, Ruben
  • Paramasivam, Nagarajan
  • Kabbe, Rolf
  • Chotewutmontri, Sasithorn
  • Diessl, Nicolle
  • Previti, Christopher
  • Schmidt, Sabine
  • Brors, Benedikt
  • Feuerbach, Lars
  • Heinold, Michael
  • Gröbner, Susanne
  • Korshunov, Andrey
  • Tarpey, Patrick
  • Butler, Adam P.
  • Hinton, Jonathan
  • Jones, David T.W.
  • Menzies, Andrew
  • Raine, Keiran
  • Shepherd, Rebecca
  • Stebbings, Lucy
  • Teague, John W.
  • Ribeca, Paolo
  • Castro Giner, Francesc
  • Beltran i Agulló, Sergi
  • Raineri, Emanuele
  • Dabad, Marc
  • Heath, Simon C.
  • Gut, Marta
  • Denroche, Robert E.
  • Harding, Nicholas J.
  • Yamaguchi, Takafumi N.
  • Nakagawa, Hidewaki
  • Quesada, Victor
  • Valdés Mas, Rafael
  • Nakken, Sigve
  • Vodák, Daniel
  • Bower, Lawrence
  • Lynch, Andrew G.
  • Anderson, Charlotte L.
  • Waddell, Nicola
  • Pearson, John V.
  • Grimmond, Sean M.
  • Peto, Myron
  • Spellman, Paul
  • He, Minghui
  • Kandoth, Cyriac
  • Lee, Semin
  • Zhang, John
  • Létourneau, Louis
  • Ma, Singer
  • Seth, Sahil
  • Torrents Arenales, David
  • Xi, Liu
  • Wheeler, David A.
  • López-Otin, Carlos
  • Campo Güerri, Elias
  • Campbell, Peter J.
  • Boutros, Paul C.
  • Puente, Xose S.
  • Gerhard, Daniela S.
  • Pfister, Stefan M.
  • McPherson, John D.
  • Hudson, Thomas J.
  • Schlesner, Matthias
  • Lichter, Peter
  • Eils, Roland
  • Jones, David T.W.
  • Gut, Ivo G.
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding of the variables affecting sequencing analysis output is required. Here using tumour-normal sample pairs from two different types of cancer, chronic lymphocytic leukaemia and medulloblastoma, we conduct a benchmarking exercise within the context of the International Cancer Genome Consortium. We compare sequencing methods, analysis pipelines and validation methods. We show that using PCR-free methods and increasing sequencing depth to ∼ 100 × shows benefits, as long as the tumour:control coverage ratio remains balanced. We observe widely varying mutation call rates and low concordance among analysis pipelines, reflecting the artefact-prone nature of the raw data and lack of standards for dealing with the artefacts. However, we show that, using the benchmark mutation set we have created, many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identification of gene mutations and fusion genes in patients with Sézary syndrome.

  • Prasad, Aparna
  • Rabionet Janssen, Raquel
  • Espinet Solà, Blanca
  • Zapata Ortiz, Luis, 1985-
  • Puiggros Metje, Anna Maria
  • Melero Vilella, Maria Carme
  • Puig, Anna
  • Sarria-Trujillo, Yaris
  • Ossowski, Stephan
  • Garcia-Muret, Maria P.
  • Estrach, Teresa
  • Servitje, Octavio
  • Lopez-Lerma, Ingrid
  • Gallardo Hernández, Fernando
  • Pujol Vallverdú, Ramón M.
  • Estivill, Xavier, 1955-
Sézary syndrome is a leukemic form of cutaneous T-cell lymphoma with an aggressive clinical course. The genetic etiology of the disease is poorly understood, with chromosomal abnormalities and mutations in some genes being involved in the disease. The goal of our study was to understand the genetic basis of the disease by looking for driver gene mutations and fusion genes in 15 erythrodermic patients with circulating Sézary cells, 14 of them fulfilling the diagnostic criteria of Sézary syndrome. We have discovered genes that could be involved in the pathogenesis of Sézary syndrome. Some of the genes that are affected by somatic point mutations include ITPR1, ITPR2, DSC1, RIPK2, IL6, and RAG2, with some of them mutated in more than one patient. We observed several somatic copy number variations shared between patients, including deletions and duplications of large segments of chromosome 17. Genes with potential function in the T-cell receptor signaling pathway and tumorigenesis were disrupted in Sézary syndrome patients, for example, CBLB, RASA2, BCL7C, RAMP3, TBRG4, and DAD1. Furthermore, we discovered several fusion events of interest involving RASA2, NFKB2, BCR, FASN, ZEB1, TYK2, and SGMS1. Our work has implications for the development of potential therapeutic approaches for this aggressive disease., This project was funded by “Retos de la Sociedad 2013: Europa Redes y Gestores” Programme from the Spanish Ministry of Economy and Competitiveness no. SAF2013-49108-R (to XE) and RD12/0036/0044 Red Temática de Investigación Cooperativa en Cancer, Fondo Europeo de Desarrollo Regional (to BE, FG, and RP), the Generalitat de Catalunya AGAUR 2014 SGR-1138 (to XE) and 2014 SGR-585 (to BE, A Puiggros, and FG), the European Commission 7th Framework Program (FP7/2007-2013) under grant agreement 282510 (A BLUEPRINT of haematopoietic Epigenomes to XE) and 262055 (European Sequencing and Genotyping Infrastructure to XE), Instituto de Salud Carlos III FEDER (PT13/0010/0005), and the “Xarxa de Bancs de tumors sponsored by Pla Director d’Oncologia de Catalunya.” We would also like to thank “Xarxa de Limfomes Cutanis de Catalunaya.” A Prasad is a Marie Curie Postdoctoral fellow supported by the European Commission 7th framework program (FP7/2007-2013) under grant agreement no. 625356. We acknowledge the support of the Spanish Ministry of Economy and Competitiveness, Centro de Excelencia Severo Ochoa 2013-2017, SEV-2012-0208.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index

  • Hinney, Anke
  • Price Foundation Collaborative Group
  • Sunyer Deu, Jordi
  • Hebebrand, Johannes
The maintenance of normal body weight is disrupted in patients with anorexia nervosa (AN) for prolonged periods of time. Prior to the onset of AN, premorbid body mass index (BMI) spans the entire range from underweight to obese. After recovery, patients have reduced rates of overweight and obesity. As such, loci involved in body weight regulation may also be relevant for AN and vice versa. Our primary analysis comprised a cross-trait analysis of the 1000 single-nucleotide polymorphisms (SNPs) with the lowest P-values in a genome-wide association meta-analysis (GWAMA) of AN (GCAN) for evidence of association in the largest published GWAMA for BMI (GIANT). Subsequently we performed sex-stratified analyses for these 1000 SNPs. Functional ex vivo studies on four genes ensued. Lastly, a look-up of GWAMA-derived BMI-related loci was performed in the AN GWAMA. We detected significant associations (P-values <5 × 10-5, Bonferroni-corrected P<0.05) for nine SNP alleles at three independent loci. Interestingly, all AN susceptibility alleles were consistently associated with increased BMI. None of the genes (chr. 10: CTBP2, chr. 19: CCNE1, chr. 2: CARF and NBEAL1; the latter is a region with high linkage disequilibrium) nearest to these SNPs has previously been associated with AN or obesity. Sex-stratified analyses revealed that the strongest BMI signal originated predominantly from females (chr. 10 rs1561589; Poverall: 2.47 × 10-06/Pfemales: 3.45 × 10-07/Pmales: 0.043). Functional ex vivo studies in mice revealed reduced hypothalamic expression of Ctbp2 and Nbeal1 after fasting. Hypothalamic expression of Ctbp2 was increased in diet-induced obese (DIO) mice as compared with age-matched lean controls. We observed no evidence for associations for the look-up of BMI-related loci in the AN GWAMA. A cross-trait analysis of AN and BMI loci revealed variants at three chromosomal loci with potential joint impact. The chromosome 10 locus is particularly promising given that the association with obesity was primarily driven by females. In addition, the detected altered hypothalamic expression patterns of Ctbp2 and Nbeal1 as a result of fasting and DIO implicate these genes in weight regulation., The authors express their gratitude to all participants. We thank the following sources for funding or research: the German Ministry for Education and Research (National Genome Research Net-Plus 01GS0820 and 01KU0903; AS, MK and the CSCC were supported by 01EO1002, 01EO1502), the German Research Foundation (DFG; HI865/2-1, SFB940/1, SCHE1648/1-3, TS226/3-1), the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement n°245009 and n°262055, and the National Institutes of Health (NIH; R01DK075787), funding to MHT from the Alexander von Humboldt Foundation, the Helmholtz Alliance ICEMED – Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association, the Helmholtz cross-program topic “Metabolic Dysfunction”, the WTCCC3 WT088827/Z/09 entitled “A genome wide association study of anorexia nervosa”.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Biallelic loss-of-function LACC1/FAMIN mutations presenting as rheumatoid factor-negative polyarticular juvenile idiopathic arthritis

  • Rabionet Janssen, Raquel
  • Remesal, Agustín
  • Mensa Vilaró, Anna
  • Murías, Sara
  • Alcobendas, Rosa
  • González-Roca, Eva
  • Ruíz Ortiz, Estíbaliz
  • Antón, Jordi
  • Iglesias, Estibaliz
  • Modesto, Consuelo
  • Comas, David, 1969-
  • Puig, Anna
  • Drechsel, Oliver
  • Ossowski, Stephan
  • Yagüe, Jordi L.
  • Merino, Rosa
  • Estivill, Xavier, 1955-
  • Aróstegui Gorospe, Juan Ignacio
Juvenile idiopathic arthritis (JIA) is a complex rheumatic disease with both autoimmune and autoinflammatory components. Recently, familial cases of systemic-onset JIA have been attributed to mutations in LACC1/FAMIN. We describe three affected siblings from a Moroccan consanguineous family with an early-onset chronic, symmetric and erosive arthritis previously diagnosed as rheumatoid factor (RF)-negative polyarticular JIA. Autozygosity mapping identified four homozygous regions shared by all patients, located in chromosomes 3, 6 (n:2) and 13, containing over 330 genes. Subsequent whole exome sequencing identified two potential candidate variants within these regions (in FARS2 and LACC1/FAMIN). Genotyping of a cohort of healthy Moroccan individuals (n: 352) and bioinformatics analyses finally supported the frameshift c.128_129delGT mutation in the LACC1/FAMIN gene, leading to a truncated protein (p.Cys43Tyrfs*6), as the most probable causative gene defect. Additional targeted sequencing studies performed in patients with systemic-onset JIA (n:23) and RF-negative polyarticular JIA (n: 44) revealed no pathogenic LACC1/FAMIN mutations. Our findings support the homozygous genotype in the LACC1/FAMIN gene as the defect underlying the family here described with a recessively inherited severe inflammatory joint disease. Our evidences provide further support to the involvement of LACC1/FAMIN deficiency in different types of JIA in addition to the initially described systemic-onset JIA., This work has been partially funded by: CERCA Programme/Generalitat de Catalunya (JIA, XE, SO), the PERIS program of the Generalitat de Catalunya grant SLT002/16/00310 (RR), the Spanish Ministry of Economy and Competitiveness co-financed by European Regional Development Fund (ERDF) grant SAF2015-68472-C2-1-R (JIA), the Instituto de Salud Carlos III/Transnational Research Projects on Rare Diseases (JIA) grant AC15/00027, the Spanish Society of Pediatric Rheumatology (JIA), the Secretaria d’Universitats i Recerca del Departament d’Economia grant 2009-SGR-1502 (XE) and the European Union Seventh Framework Programme (FP7/2007-2013) grant agreement no. 262055 (XE).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identification of gene mutations and fusion genes in patients with Sézary Syndrome

  • Prasad, Aparna
  • Rabionet Janssen, Raquel
  • Espinet Solà, Blanca
  • Zapata, Luis
  • Puiggròs Metje, Anna Maria
  • Melero, Carme
  • Puig, Anna
  • Sarria Trujillo, Yaris
  • Ossowski, Stephan
  • Garcia-Muret, Maria P.
  • Estrach Panella, Ma. Teresa (María Teresa)
  • Servitje Bedate, Octavio
  • Lopez Lerma, Ingrid
  • Gallardo, F. (Fernando)
  • Pujol, Ramon M.
  • Estivill, Xavier, 1955-
Sézary syndrome is a leukemic form of cutaneous T-cell lymphoma with an aggressive clinical course. The genetic etiology of the disease is poorly understood, with chromosomal abnormalities and mutations in some genes being involved in the disease. The goal of our study was to understand the genetic basis of the disease by looking for driver gene mutations and fusion genes in 15 erythrodermic patients with circulating Sézary cells, 14 of them fulfilling the diagnostic criteria of Sézary syndrome. We have discovered genes that could be involved in the pathogenesis of Sézary syndrome. Some of the genes that are affected by somatic point mutations include ITPR1, ITPR2, DSC1, RIPK2, IL6, and RAG2, with some of them mutated in more than one patient. We observed several somatic copy number variations shared between patients, including deletions and duplications of large segments of chromosome 17. Genes with potential function in the T-cell receptor signaling pathway and tumorigenesis were disrupted in Sézary syndrome patients, for example, CBLB, RASA2, BCL7C, RAMP3, TBRG4, and DAD1. Furthermore, we discovered several fusion events of interest involving RASA2, NFKB2, BCR, FASN, ZEB1, TYK2, and SGMS1. Our work has implications for the development of potential therapeutic approaches for this aggressive disease.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Container-aided integrative QTL and RNA-seq analysis of Collaborative Cross mice supports distinct sex-oriented molecular modes of response in obesity

  • Binenbaum, Ilona
  • Atamni, Hanifa Abu-Toamih
  • Fotakis, Georgios
  • Kontogianni, Georgia
  • Koutsandreas, Theodoros
  • Pilalis, Eleftherios
  • Mott, Richard
  • Himmelbauer, Heinz
  • Iraqi, Fuad A.
  • Chatziioannou, Aristotelis A.
Background: The Collaborative Cross (CC) mouse population is a valuable resource to study the genetic basis of complex traits, such as obesity. Although the development of obesity is influenced by environmental factors, underlying genetic mechanisms play a crucial role in the response to these factors. The interplay between the genetic background and the gene expression pattern can provide further insight into this response, but we lack robust and easily reproducible workflows to integrate genomic and transcriptomic information in the CC mouse population. Results: We established an automated and reproducible integrative workflow to analyse complex traits in the CC mouse genetic reference panel at the genomic and transcriptomic levels. We implemented the analytical workflow to assess the underlying genetic mechanisms of host susceptibility to diet induced obesity and integrated these results with diet induced changes in the hepatic gene expression of susceptible and resistant mice. Hepatic gene expression differs significantly between obese and non-obese mice, with a significant sex effect, where male and female mice exhibit different responses and coping mechanisms. Conclusion: Integration of the data showed that different genes but similar pathways are involved in the genetic susceptibility and disturbed in diet induced obesity. Genetic mechanisms underlying susceptibility to high-fat diet induced obesity are different in female and male mice. The clear distinction we observed in the systemic response to the high-fat diet challenge and to obesity between male and female mice points to the need for further research into distinct sex-related mechanisms in metabolic disease., This work was funded by the Operational Program ”Competitiveness, Entrepreneurship and Innovation 2014–2020″ (co-funded by the European Regional Development Fund) and managed by the General Secretariat of Research and Technology, Ministry Of Education, Research & Religious Affairs, under the project” Innovative Nanopharmaceuticals: Targeting Breast CancerStem Cells by a Novel Combination of Epigenetic and Anticancer Drugs with Gene Therapy (INNOCENT)” (7th Joint Translational Call - 2016, European Innovative Research and Technological Development Projects In Nanomedicine) of the ERA-NET EuroNanoMed II and by “BioS: Digital Skills on Computational Biology”, ΕRASMUS+, EACEA/04/2017, “KA2: Cooperation for innovation and the exchange of good practices - Sector Skills Alliances” for the development of the bioinformatic analysis pipeline, Hendrech and Eiran Gotwert Fund for studying diabetes, Wellcome Trust grants 085906/Z/ 08/Z, 075491/Z/04 and 090532/Z/09/Z; for financially supporting the initiation, breeding, genotyping and maintaining the CC mouse colony at TAU, core funding by Tel-Aviv University (TAU) for supporting staff at Iraqi’s lab, Israeli Science foundation (ISF) grants 429/09 and 1085/18, Binational Science Foundation (BSF) grant number 2015077 and German Israeli Science Foundation (GIF) grant I-63-410.20-2017 for performing the mouse assessment for T2D and technical staff, and European Sequencing and Genotyping Infrastructure (ESGI) consortium grant for conducting the RNAseq analysis.Ilona Binenbaum’s PhD thesis was supported by a scholarship from the State Scholarship Foundation in Greece (IKY) (Operational Program “Human Resources Development - Education and Lifelong Learning” Partnership Agreement (PA) 2014–2020)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The European Genome-phenome Archive of human data consented for biomedical research

  • Lappalainen, Ilkka
  • Carreño Torres, Angel
  • Rambla de Argila, Jordi
  • Martinez Llobet, Oscar
  • Sitges Puy, Marc
  • Alberich, Mario
  • Torre, Sabela de la
  • Navarro i Cuartiellas, Arcadi, 1969-
  • Flicek, Paul
The European Genome-phenome Archive (EGA) is a permanent archive that promotes the distribution and sharing of genetic and phenotypic data consented for specific approved uses but not fully open, public distribution. The EGA follows strict protocols for information management, data storage, security and dissemination. Authorized access to the data is managed in partnership with the data-providing organizations. The EGA includes major reference data collections for human genetics research., The EGA has received support from the European Molecular Biology Laboratory, the European Union ELIXIR Technical Feasibility Study, the Wellcome Trust (grant WT 085475/C/08/Z), the UK Medical Research Council (grant G0800681), the Spanish Instituto de Salud Carlos III Instituto Nacional de Bioinformática (grant PT13/0001/0026), the Spanish Ministerio de Economía y Competitividad (MINECO) and Centro de Excelencia Severo Ochoa (grant SEV-2012-0208), the Fundació La Caixa and the Barcelona Supercomputing Centre. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013 under grant agreements 211601–ELIXIR, 200754–GEN2PHEN, 262055–ESGI, 242006–BASIS, 261376–IHMS and 305444–RD-CONNECT).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Biallelic loss-of-function LACC1/FAMIN mutations presenting as rheumatoid factor-negative polyarticular juvenile idiopathic arthritis

  • Rabionet Janssen, Raquel
  • Remesal, Agustín
  • Mensa Vilaró, Anna
  • Murías, Sara
  • Alcobendas, Rosa
  • González-Roca, Eva
  • Ruiz Ortiz, Estíbaliz
  • Antón López, Jordi
  • Iglesias Jiménez, Estíbaliz
  • Modesto, Consuelo
  • Comas, David
  • Puig, Anna
  • Drechsel, Oliver
  • Ossowski, Stephan
  • Yagüe, Jordi
  • Merino, Rosa
  • Estivill, Xavier, 1955-
  • Aróstegui Gorospe, Juan Ignacio
Juvenile idiopathic arthritis (JIA) is a complex rheumatic disease with both autoimmune and autoinflammatory components. Recently, familial cases of systemic-onset JIA have been attributed to mutations in LACC1/FAMIN. We describe three affected siblings from a Moroccan consanguineous family with an early-onset chronic, symmetric and erosive arthritis previously diagnosed as rheumatoid factor (RF)-negative polyarticular JIA. Autozygosity mapping identified four homozygous regions shared by all patients, located in chromosomes 3, 6 (n:2) and 13, containing over 330 genes. Subsequent whole exome sequencing identified two potential candidate variants within these regions (in FARS2 and LACC1/FAMIN). Genotyping of a cohort of healthy Moroccan individuals (n: 352) and bioinformatics analyses finally supported the frameshift c.128_129delGT mutation in the LACC1/FAMIN gene, leading to a truncated protein (p.Cys43Tyrfs*6), as the most probable causative gene defect. Additional targeted sequencing studies performed in patients with systemic-onset JIA (n:23) and RF-negative polyarticular JIA (n: 44) revealed no pathogenic LACC1/FAMIN mutations. Our findings support the homozygous genotype in the LACC1/FAMIN gene as the defect underlying the family here described with a recessively inherited severe inflammatory joint disease. Our evidences provide further support to the involvement of LACC1/FAMIN deficiency in different types of JIA in addition to the initially described systemic-onset JIA.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

PeSV-Fisher: identification of somatic and non-somatic structural variants using nextgeneration sequencing data

  • Escaramís, Geòrgia
  • Tornador Antolin, Cristian, 1979-
  • Bassaganyas Bars, Laia, 1985-
  • Rabionet Janssen, Raquel
  • Tubio, José M. C.
  • Martínez Fundichely, Alexander, 1978-
  • Cáceres Aguilar, Mario
  • Gut, Marta
  • Ossowski, Stephan
  • Estivill, Xavier, 1955-
Next-generation sequencing technologies expedited research to develop efficient computational tools for the identification of structural variants (SVs) and their use to study human diseases. As deeper data is obtained, the existence of higher complexity SVs in some genomes becomes more evident, but the detection and definition of most of these complex rearrangements is still in its infancy. The full characterization of SVs is a key aspect for discovering their biological implications. Here we present a pipeline (PeSV-Fisher) for the detection of deletions, gains, intra- and inter-chromosomal translocations, and inversions, at very reasonable computational costs. We further provide comprehensive information on co-localization of SVs in the genome, a crucial aspect for studying their biological consequences. The algorithm uses a combination of methods based on paired-reads and read-depth strategies. PeSV-Fisher has been designed with the aim to facilitate identification of somatic variation, and, as such, it is capable of analysing two or more samples simultaneously, producing a list of non-shared variants between samples. We tested PeSV-Fisher on available sequencing data, and compared its behaviour to that of frequently deployed tools (BreakDancer and VariationHunter). We have also tested this algorithm on our own sequencing data, obtained from a tumour and a normal blood sample of a patient with chronic lymphocytic leukaemia, on which we have also validated the results by targeted re-sequencing of different kinds of predictions. This allowed us to determine confidence parameters that influence the reliability of breakpoint predictions., This work was supported by AGAUR (Generalitat de Catalunya, 2009 SGR 1502) (X.E.); CIBERESP (Instituto de Salud Carlos III) (G.E.); ESGI (European Commission, 262055_ESGI) (R.R., X.E.), ENGAGE (European Commission, ENGAGE_201413), TECHGENE (European Commission, TECHGENE_223143), and GEUVADIS (European Commission, 261123_GEUVADIS) (X.E.); NOVADIS (Ministerio de Ciencia y Technologia, SAF2008-00357) (X.E.); Galicia Government Xunta de Galicia (Spain) through the project number 10PXIB918057 (J.M.C.T.); MAEC-AEC1 Predoctoral Fellowship (Ministerio de Asuntos Exteriores y Cooperación, Spain) (A.M.F.); and Ramón y Cajal position and grant BFU2007-60930 (Ministerio de Educación y Ciencia) (M.C.).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia.

  • Costas, Javier
  • Carrera, Noa
  • Alonso, Pino
  • Gurriarán, X.
  • Segalàs, Cinto
  • Real, Eva
  • López-Solà, Clara
  • Mas, Sebastian
  • Gassó, Patricia
  • Domènech Salgado, Laura, 1989-
  • Morell, Marta
  • Quintela Garcia, Ines
  • Lázaro, Luisa
  • Menchón, José M.
  • Estivill, Xavier, 1955-
  • Carracedo, Ángel
Common single-nucleotide polymorphisms (SNPs) account for a large proportion of the heritability of obsessive-compulsive disorder (OCD). Co-ocurrence of OCD and schizophrenia is commoner than expected based on their respective prevalences, complicating the clinical management of patients. This study addresses two main objectives: to identify particular genes associated with OCD by SNP-based and gene-based tests; and to test the existence of a polygenic risk shared with schizophrenia. The primary analysis was an exon-focused genome-wide association study of 370 OCD cases and 443 controls from Spain. A polygenic risk model based on the Psychiatric Genetics Consortium schizophrenia data set (PGC-SCZ2) was tested in our OCD data. A polygenic risk model based on our OCD data was tested on previous data of schizophrenia from our group. The most significant association at the gene-based test was found at DNM3 (P=7.9 × 10(-5)), a gene involved in synaptic vesicle endocytosis. The polygenic risk model from PGC-SCZ2 data was strongly associated with disease status in our OCD sample, reaching its most significant value after removal of the major histocompatibility complex region (lowest P=2.3 × 10(-6), explaining 3.7% of the variance). The shared polygenic risk was confirmed in our schizophrenia data. In conclusion, DNM3 may be involved in risk to OCD. The shared polygenic risk between schizophrenia and OCD may be partially responsible for the frequent comorbidity of both disorders, explaining epidemiological data on cross-disorder risk. This common etiology may have clinical implications., The study was supported by Fundación María José Jove, Fondo Europeo de Desarrollo Regional (FEDER), Xunta de Galicia; and by grants from the Instituto de Salud Carlos III FIS PI13/01136 to AC, CP11/00163 to JC, PI13/00918 to JMM, PI14/00413 to PA; the Generalitat de Catalunya AGAUR 2014 SGR-1138; the Spanish MINIECO SAF2013-49108- R Plan Estatal; and the European Commission 7th Framework Program, Project N. 262055 (ESGI) to XE. LD is supported by a Severo Ochoa fellowship of the Spanish MINIECO.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Whole genome and exome sequencing of monozygotic twins discordant for Crohn's disease

  • Petersen, Britt-Sabina
  • Spehlmann, Martina E.
  • Raedler, Andreas
  • Stade, Björn
  • Thomsen, Ingo
  • Rabionet Janssen, Raquel
  • Rosenstiel, Philip
  • Schreiber, Stefan
  • Franke, Andre
Background Crohn's disease (CD) is an inflammatory bowel disease caused by genetic and environmental factors. More than 160 susceptibility loci have been identified for IBD, yet a large part of the genetic variance remains unexplained. Recent studies have demonstrated genetic differences between monozygotic twins, who were long thought to be genetically completely identical. Results We aimed to test if somatic mutations play a role in CD etiology by sequencing the genomes and exomes of directly affected tissue from the bowel and blood samples of one and the blood-derived exomes of two further monozygotic discordant twin pairs. Our goal was the identification of mutations present only in the affected twins, pointing to novel candidates for CD susceptibility loci. We present a thorough genetic characterization of the sequenced individuals but detected no consistent differences within the twin pairs. An estimate of the CD susceptibility based on known CD loci however hinted at a higher mutational load in all three twin pairs compared to 1,920 healthy individuals. Conclusion Somatic mosaicism does not seem to play a role in the discordance of monozygotic CD twins. Our study constitutes the first to perform whole genome sequencing for CD twins and therefore provides a valuable reference dataset for future studies. We present an example framework for mosaicism detection and point to the challenges in these types of analyses.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing

  • Alioto, Tyler
  • Derdak, Sophia
  • Ribeca, Paolo
  • Castro Giner, Francesc
  • Beltran, Sergi
  • Raineri, Emanuele
  • Dabad, Marc
  • Heath, Simon
  • Gut, Marta
  • Gut, Ivo Glynne
Includes supplementary materials: online appendix; replication file, As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding of the variables affecting sequencing analysis output is required. Here using tumour-normal sample pairs from two different types of cancer, chronic lymphocytic leukaemia and medulloblastoma, we conduct a benchmarking exercise within the context of the International Cancer Genome Consortium. We compare sequencing methods, analysis pipelines and validation methods. We show that using PCR-free methods and increasing sequencing depth to ∼100 × shows benefits, as long as the tumour:control coverage ratio remains balanced. We observe widely varying mutation call rates and low concordance among analysis pipelines, reflecting the artefact-prone nature of the raw data and lack of standards for dealing with the artefacts. However, we show that, using the benchmark mutation set we have created, many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy., We thank the DKFZ Genomics and Proteomics Core Facility and the OICR Genome Technologies Platform for provision of sequencing services. Financial support was provided by the consortium projects READNA under grant agreement FP7 Health-F4-2008-201418, ESGI under grant agreement 262055, GEUVADIS under grant agreement 261123 of the European Commission Framework Programme 7, ICGC-CLL through the Spanish Ministry of Science and Innovation (MICINN), the Instituto de Salud Carlos III (ISCIII) and the Generalitat de Catalunya. Additional financial support was provided by the PedBrain Tumor Project contributing to the ICGC, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants #01KU1201A, MedSys #0315416C and NGFNplus #01GS0883), the BMBF-funded ICGC projects on early-onset prostate cancer and malignant lymphoma (#01KU1001A, #01KU1002B) and via the BMBF-funded de.NBI HD-HuB network (#031A537A, #031A537C); the Ontario Institute for Cancer Research to PCB and JDM through funding provided by the Government of Ontario, Ministry of Research and Innovation; Genome Canada; the Canada Foundation for Innovation and Prostate Cancer Canada with funding from the Movember Foundation (PCB). P.C.B. was also supported by a Terry Fox Research Institute New Investigator Award, a CIHR New Investigator Award and a Genome Canada Large-Scale Applied Project Contract. The Synergie Lyon Cancer platform has received support from the French National Institute of Cancer (INCa) and from the ABS4NGS ANR project (ANR-11-BINF-0001-06). The ICGC RIKEN study was supported partially by RIKEN President’s Fund 2011, and the supercomputing resource for the RIKEN study was provided by the Human Genome Center, University of Tokyo. M.D.E., L.B., A.G.L. and C.L.A. were supported by Cancer Research UK, the University of Cambridge and Hutchison-Whampoa Limited. S.D. is supported by the Torres Quevedo subprogramme (MICINN) under grant agreement PTQ-12-05391. E.H. is supported by the Research Council of Norway under grant agreements 221580 and 218241 and by the Norwegian Cancer Society under grant agreement 71220—PR-2006-0433. We specially thank Jennifer Jennings for administrating the activity of the ICGC Verification Working Group and Anna Borrell for administrative support.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia

  • Costas, Javier
  • Carrera, Noa
  • Alonso, Pino
  • Gurriarán, X.
  • Segalàs Cosi, Cinto
  • Real, Eva
  • López Solà, Clara
  • Mas Herrero, Sergi
  • Gassó Astorga, Patricia
  • Domènech, Lluis
  • Morell, Marta
  • Quintela, Inés
  • Lázaro García, Luisa
  • Menchón Magriñá, José Manuel
  • Estivill, Xavier, 1955-
  • Carracedo, Arkaitz
Common single-nucleotide polymorphisms (SNPs) account for a large proportion of the heritability of obsessive-compulsive disorder (OCD). Co-ocurrence of OCD and schizophrenia is commoner than expected based on their respective prevalences, complicating the clinical management of patients. This study addresses two main objectives: to identify particular genes associated with OCD by SNP-based and gene-based tests; and to test the existence of a polygenic risk shared with schizophrenia. The primary analysis was an exon-focused genome-wide association study of 370 OCD cases and 443 controls from Spain. A polygenic risk model based on the Psychiatric Genetics Consortium schizophrenia data set (PGC-SCZ2) was tested in our OCD data. A polygenic risk model based on our OCD data was tested on previous data of schizophrenia from our group. The most significant association at the gene-based test was found at DNM3 (P=7.9 × 10(-5)), a gene involved in synaptic vesicle endocytosis. The polygenic risk model from PGC-SCZ2 data was strongly associated with disease status in our OCD sample, reaching its most significant value after removal of the major histocompatibility complex region (lowest P=2.3 × 10(-6), explaining 3.7% of the variance). The shared polygenic risk was confirmed in our schizophrenia data. In conclusion, DNM3 may be involved in risk to OCD. The shared polygenic risk between schizophrenia and OCD may be partially responsible for the frequent comorbidity of both disorders, explaining epidemiological data on cross-disorder risk. This common etiology may have clinical implications.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Dissecting the effect of genetic variation on the hepatic expression of drug disposition genes across the collaborative cross mouse strains

  • Nachshon, Aharon
  • Abu-Toamih Atamni, Hanifa Jalal
  • Steuerman, Yael
  • Sheikh-Hamed, Roa&apos;a
  • Dorman, Alexandra
  • Mott, Richard
  • Dohm, Juliana C.
  • Lehrach, Hans
  • Sultan, Marc
  • Shamir, Ron
  • Sauer, Sascha
  • Himmelbauer, Heinz
  • Iraqi, Fuad A.
  • Gat-Viks, Irit
A central challenge in pharmaceutical research is to investigate genetic variation in response to drugs. The Collaborative Cross (CC) mouse reference population is a promising model for pharmacogenomic studies because of its large amount of genetic variation, genetic reproducibility, and dense recombination sites. While the CC lines are phenotypically diverse, their genetic diversity in drug disposition processes, such as detoxification reactions, is still largely uncharacterized. Here we systematically measured RNA-sequencing expression profiles from livers of 29 CC lines under baseline conditions. We then leveraged a reference collection of metabolic biotransformation pathways to map potential relations between drugs and their underlying expression quantitative trait loci (eQTLs). By applying this approach on proximal eQTLs, including eQTLs acting on the overall expression of genes and on the expression of particular transcript isoforms, we were able to construct the organization of hepatic eQTL-drug connectivity across the CC population. The analysis revealed a substantial impact of genetic variation acting on drug biotransformation, allowed mapping of potential joint genetic effects in the context of individual drugs, and demonstrated crosstalk between drug metabolism and lipid metabolism. Our findings provide a resource for investigating drug disposition in the CC strains, and offer a new paradigm for integrating biotransformation reactions to corresponding variations in DNA sequences., This work was supported by the European Commission [FP7/2007-2013, under grant agreement no. 262055 (ESGI)], by the Israeli Centers of Research Excellence (I-CORE): Center No. 41/11, by the Broad-ISF grant 1168/14, and by the Wellcome Trust grants 090532/Z/09/Z, 085906/Z/08/Z, 083573/Z/07/Z, and 075491/Z/04. Research in the IG lab was supported by the European Research Council (637885), and by the Israeli Science Foundation (ISF) grant 1643/13. YS was partially supported by the Edmond J. Safra Center for Bioinformatics at Tel Aviv University IG is a Faculty Fellow of the Edmond J. Safra Center for Bioinformatics at Tel Aviv University and an Alon Fellow. RS was supported in part by the Raymond and Beverly Sackler Chair in Bioinformatics.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing

  • Trujillano Lidón, Daniel, 1987-
  • Bullich, Gemma
  • Ossowski, Stephan
  • Ballarín, José
  • Torra, Roser
  • Estivill, Xavier, 1955-
  • Ars, Elisabet
Molecular diagnostics of autosomal dominant polycystic kidney disease (ADPKD) relies on mutation screening of PKD1 and PKD2, which is complicated by extensive allelic heterogeneity and the presence of six highly homologous sequences of PKD1. To date, specific sequencing of PKD1 requires laborious long-range amplifications. The high cost and long turnaround time of PKD1 and PKD2 mutation analysis using conventional techniques limits its widespread application in clinical settings. We performed targeted next-generation sequencing (NGS) of PKD1 and PKD2. Pooled barcoded DNA patient libraries were enriched by in-solution hybridization with PKD1 and PKD2 capture probes. Bioinformatics analysis was performed using an in-house developed pipeline. We validated the assay in a cohort of 36 patients with previously known PKD1 and PKD2 mutations and five control individuals. Then, we used the same assay and bioinformatics analysis in a discovery cohort of 12 uncharacterized patients. We detected 35 out of 36 known definitely, highly likely, and likely pathogenic mutations in the validation cohort, including two large deletions. In the discovery cohort, we detected 11 different pathogenic mutations in 10 out of 12 patients. This study demonstrates that laborious long-range PCRs of the repeated PKD1 region can be avoided by in-solution enrichment of PKD1 and PKD2 and NGS. This strategy significantly reduces the cost and time for simultaneous PKD1 and PKD2 sequence analysis, facilitating routine genetic diagnostics of ADPKD., This project was funded by the Spanish Plan Nacional SAF2008-00357 (NOVADIS); the Instituto de Salud Carlos III (FIS/FEDER PI11/00733; PI12/01523 and PI13/01731); the European Commission/n7th Framework Program, Project N. 261123 (GEUVADIS), and Project N. 262055 (ESGI); Spanish Renal Network for Research 16/06, RETICS, Instituto de Investigación Carlos III: REDinREN/RD06/0016 and RD012/0021 FEDER funds; the Catalan Government (AGAUR/n2009/SGR-1116); and the Fundación Renal Iñigo Álvarez de Toledo in Spain. D. T. is a PhD student supported by the Spanish Ministry of Economy and Competiveness. R. T. is supported by Intensification Programm of Research Activity ISCIII/Generalitat de Catalunya (programm I3SN). We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de/nExcelencia Severo Ochoa 2013-2017’, SEV-2012-0208.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A decade of structural variants: description, history and methods to detect structural variation

  • Escaramís, Geòrgia
  • Docampo, Elisa
  • Rabionet Janssen, Raquel
In the past decade, the view on genomic structural variation (SV) has been changed completely. SVs, previously considered rare events, are now recognized as the largest source of interindividual genetic variation affecting more bases than single nucleotide polymorphisms, variable number of tandem repeats and other small genetic variants. They have also been shown to play a role in phenotypic variation and in disease. In this review, the authors will provide an introduction to SV; a short historical perspective on the research of this source of genomic variation; a description of the types of structural variants, and on how they may have arisen; and an overview on methods of detecting structural variants, focusing on the analysis of high-throughput sequencing data., E.D. is supported by a Marie Curie Intraeuropean Fellowship (IEF), R.R. is supported through the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 262055. We acknowledge support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017’, SEV-2012-0208, the ‘Secretaria d'Universitats i Recerca del Departament d'Economia’ (2009 SGR 1502) and the ‘PN de I+D+I 2008-2011’ and ISCIII (SAF2008-00357). The research leading to these results reflects only the author s views and the funding agencies are not liable for any use that may be made of the information contained in this paper.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing

  • Alioto, Tyler S.
  • Buchhalter, Ivo
  • Derdak, Sophie
  • Torrents Rodas, David
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding of the variables affecting sequencing analysis output is required. Here using tumour-normal sample pairs from two different types of cancer, chronic lymphocytic leukaemia and medulloblastoma, we conduct a benchmarking exercise within the context of the International Cancer Genome Consortium. We compare sequencing methods, analysis pipelines and validation methods. We show that using PCR-free methods and increasing sequencing depth to ~100 × shows benefits, as long as the tumour:control coverage ratio remains balanced. We observe widely varying mutation call rates and low concordance among analysis pipelines, reflecting the artefact-prone nature of the raw data and lack of standards for dealing with the artefacts. However, we show that, using the benchmark mutation set we have created, many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

In vivo binding of PRDM9 reveals interactions with noncanonical genomic sites

  • Grey, Corinne
  • Clément, Julie A.J.
  • Buard, Jerome
  • Leblanc, Benjamin
  • Gut, Ivo Glynne
  • Gut, Marta
  • Duret, Laurent
  • de Massy, Bernard D.
In mouse and human meiosis, DNA double-strand breaks (DSBs) initiate homologous recombination and occur at specific sites called hotspots. The localization of these sites is determined by the sequence-specific DNA binding domain of the PRDM9 histone methyl transferase. Here, we performed an extensive analysis of PRDM9 binding in mouse spermatocytes. Unexpectedly, we identified a noncanonical recruitment of PRDM9 to sites that lack recombination activity and the PRDM9 binding consensus motif. These sites include gene promoters, where PRDM9 is recruited in a DSB-dependent manner. Another subset reveals DSB-independent interactions between PRDM9 and genomic sites, such as the binding sites for the insulator protein CTCF. We propose that these DSB-independent sites result from interactions between hotspot-bound PRDM9 and genomic sequences located on the chromosome axis., The work leading to the H3K4me3 results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 262055. This work was supported by the Agence Nationale de la Recherche (ANR-15-CE12-0010-01/DaSiRe). B.d.M. was funded by grants from the Centre National pour la Recherche Scientifique (CNRS) and the European Research Council Executive Agency under the European Community's Seventh Framework Programme (FP7/2007-2013 grant agreement no. [322788]).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A genome-wide association study of anorexia nervosa

  • Fernández Aranda, Fernando
  • Jiménez-Murcia, Susana
  • Rabionet Janssen, Raquel
  • Genetic Consortium for Anorexia Nervosa
  • Wellcome Trust Case Control Consortium 3
Anorexia nervosa (AN) is a complex and heritable eating disorder characterized by dangerously low body weight. Neither candidate gene studies nor an initial genome-wide association study (GWAS) have yielded significant and replicated results. We performed a GWAS in 2907 cases with AN from 14 countries (15 sites) and 14 860 ancestrally matched controls as part of the Genetic Consortium for AN (GCAN) and the Wellcome Trust Case Control Consortium 3 (WTCCC3). Individual association analyses were conducted in each stratum and meta-analyzed across all 15 discovery data sets. Seventy-six (72 independent) single nucleotide polymorphisms were taken forward for in silico (two data sets) or de novo (13 data sets) replication genotyping in 2677 independent AN cases and 8629 European ancestry controls along with 458 AN cases and 421 controls from Japan. The final global meta-analysis across discovery and replication data sets comprised 5551 AN cases and 21 080 controls. AN subtype analyses (1606 AN restricting; 1445 AN binge-purge) were performed. No findings reached genome-wide significance. Two intronic variants were suggestively associated: rs9839776 (P = 3.01 x 10(-7)) in SOX2OT and rs17030795 (P = 5.84 x 10(-6)) in PPP3CA. Two additional signals were specific to Europeans: rs1523921 (P = 5.76 x 10(-6)) between CUL3 and FAM124B and rs1886797 (P = 8.05 x 10(-6)) near SPATA13. Comparing discovery with replication results, 76% of the effects were in the same direction, an observation highly unlikely to be due to chance (P= 4x10(-6)), strongly suggesting that true findings exist but our sample, the largest yet reported, was underpowered for their detection. The accrual of large genotyped AN case-control samples should be an immediate priority for the field.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing

  • Trujillano, Daniel
  • Bullich Vilanova, Gemma|||0000-0002-0737-4422
  • Ossowski, Stephan|||0000-0002-7416-9568
  • Ballarín Castan, José Aurelio|||0000-0002-4556-8164
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Estivill, Xavier|||0000-0002-0723-2256
  • Ars, Elisabet|||0000-0002-4118-4358
Molecular diagnostics of autosomal dominant polycystic kidney disease (ADPKD) relies on mutation screening of PKD1 and PKD2, which is complicated by extensive allelic heterogeneity and the presence of six highly homologous sequences of PKD1. To date, specific sequencing of PKD1 requires laborious long-range amplifications. The high cost and long turnaround time of PKD1 and PKD2 mutation analysis using conventional techniques limits its widespread application in clinical settings. We performed targeted next-generation sequencing (NGS) of PKD1 and PKD2. Pooled barcoded DNA patient libraries were enriched by in-solution hybridization with PKD1 and PKD2 capture probes. Bioinformatics analysis was performed using an in-house developed pipeline. We validated the assay in a cohort of 36 patients with previously known PKD1 and PKD2 mutations and five control individuals. Then, we used the same assay and bioinformatics analysis in a discovery cohort of 12 uncharacterized patients. We detected 35 out of 36 known definitely, highly likely, and likely pathogenic mutations in the validation cohort, including two large deletions. In the discovery cohort, we detected 11 different pathogenic mutations in 10 out of 12 patients. This study demonstrates that laborious long-range PCRs of the repeated PKD1 region can be avoided by in-solution enrichment of PKD1 and PKD2 and NGS. This strategy significantly reduces the cost and time for simultaneous PKD1 and PKD2 sequence analysis, facilitating routine genetic diagnostics of ADPKD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeted next-generation sequencing in steroid-resistant nephrotic syndrome, mutations in multiple glomerular genes may influence disease severity

  • Bullich Vilanova, Gemma|||0000-0002-0737-4422
  • Trujillano, Daniel
  • Santín, Sheila
  • Ossowski, Stephan|||0000-0002-7416-9568
  • Mendizábal, Santiago
  • Fraga Rodriguez, Gloria Maria|||0000-0002-7682-1396
  • Madrid, Alvaro
  • Ariceta Iraola, Gema|||0000-0003-1763-1098
  • Ballarín Castan, José Aurelio|||0000-0002-4556-8164
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Estivill, Xavier|||0000-0002-0723-2256
  • Ars, Elisabet|||0000-0002-4118-4358
Genetic diagnosis of steroid-resistant nephrotic syndrome (SRNS) using Sanger sequencing is complicated by the high genetic heterogeneity and phenotypic variability of this disease. We aimed to improve the genetic diagnosis of SRNS by simultaneously sequencing 26 glomerular genes using massive parallel sequencing and to study whether mutations in multiple genes increase disease severity. High-throughput mutation analysis was performed in 50 SRNS and/or focal segmental glomerulosclerosis (FSGS) patients, a validation cohort of 25 patients with known pathogenic mutations, and a discovery cohort of 25 uncharacterized patients with probable genetic etiology. In the validation cohort, we identified the 42 previously known pathogenic mutations across NPHS1, NPHS2, WT1, TRPC6, and INF2 genes. In the discovery cohort, disease-causing mutations in SRNS/FSGS genes were found in nine patients. We detected three patients with mutations in an SRNS/FSGS gene and COL4A3. Two of them were familial cases and presented a more severe phenotype than family members with mutation in only one gene. In conclusion, our results show that massive parallel sequencing is feasible and robust for genetic diagnosis of SRNS/FSGS. Our results indicate that patients carrying mutations in an SRNS/FSGS gene and also in COL4A3 gene have increased disease severity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

PeSV-fisher, identification of somatic and non-somatic structural variants using next generation sequencing data

  • Escaramis, Georgia
  • Tornador, Cristian
  • Bassaganyas, Laia|||0000-0002-4575-0214
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Tubio, Jose M. C.|||0000-0003-3540-2459
  • Martínez-Fundichely, Alexander
  • Cáceres Aguilar, Mario|||0000-0002-7736-3251
  • Gut, Marta|||0000-0002-4063-7159
  • Ossowski, Stephan|||0000-0002-7416-9568
  • Estivill, Xavier|||0000-0002-0723-2256
Next-generation sequencing technologies expedited research to develop efficient computational tools for the identification of structural variants (SVs) and their use to study human diseases. As deeper data is obtained, the existence of higher complexity SVs in some genomes becomes more evident, but the detection and definition of most of these complex rearrangements is still in its infancy. The full characterization of SVs is a key aspect for discovering their biological implications. Here we present a pipeline (PeSV-Fisher) for the detection of deletions, gains, intra- and inter-chromosomal translocations, and inversions, at very reasonable computational costs. We further provide comprehensive information on co-localization of SVs in the genome, a crucial aspect for studying their biological consequences. The algorithm uses a combination of methods based on paired-reads and read-depth strategies. PeSV-Fisher has been designed with the aim to facilitate identification of somatic variation, and, as such, it is capable of analysing two or more samples simultaneously, producing a list of non-shared variants between samples. We tested PeSV-Fisher on available sequencing data, and compared its behaviour to that of frequently deployed tools (BreakDancer and VariationHunter). We have also tested this algorithm on our own sequencing data, obtained from a tumour and a normal blood sample of a patient with chronic lymphocytic leukaemia, on which we have also validated the results by targeted re-sequencing of different kinds of predictions. This allowed us to determine confidence parameters that influence the reliability of breakpoint predictions.Availability:PeSV-Fisher is available at http://gd.crg.eu/tools.